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Abstract 
Dietary intake is one of the modifiable factors that may affect older adults’ cognitive 
function in their later years. Very little research has considered the potential role of dairy 
products on cognitive function. The aim of the present study was twofold: first, to 
investigate whether there is a difference in cognitive performance between older adults 
who consumed the recommended amount of dairy products (3 servings per day) and 
individuals who consumed less than the recommended amount (1 or 2 servings per day); 
second, to examine whether there is an association between the nutrients contained in the 
dairy products and cognitive performance. To do this, a cross-sectional study was 
undertaken. The Montreal Cognitive Assessment (MoCA), Rey Complex Figure Test and 
Recognition Trial (RCFT), Trail-Making Test, Victoria Stroop Test (VST) and the Digit 
Span Test (forward and backward) were used to assess cognitive function. Dietary intake 
of food group consumption was also assessed via estimated 5-day food intake records and 
analyzed for saturated fat, vitamin D, calcium and other macronutrients and 
micronutrients. In the 32 participants (8 males and 24 females) who completed the study 
(average age= 70.59± 7.07 years; BMI=27.59±4.45 kg/m^2), no differences were found 
between the group who consumed <3 servings of dairy products per day and the group 
who consumed the recommended amount of 3 servings of dairy products per day in their 
cognitive task performances. However, a number of associations were found between the 
nutrients (vitamin D, saturated fat, calcium) found in dairy products and cognitive 
performance. A positive correlation was found between the level of vitamin D and the 
RCFT, Digit Span test backward version, and the MoCA. Also, a negative correlation 
was found between the level of saturated fat and performance on the RCFT.  However, no 
association was found between calcium level in dairy products and performance on any 
of the cognitive tests. In conclusion, dairy products intake is associated with better 
cognitive performance but underlying mechanisms are still to be determined.  
Keywords: dairy, milk, cheese, yogurt, dairy products, cognitive function/dysfunction, 
cognitive performance, cognitive state, cognitive decline, and cognitive impairment 
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1 Introduction 
Older adults are among the fastest growing segments of the world population. It is 
estimated that by 2015, people aged 65 years and over will outnumber children under the 
age of five in both developing and developed countries (World Health Organization, 
National Institute of Aging & National Institute of Health, 2011). This remarkable 
increase in the number of people aged 65 years or older is projected to grow from an 
estimated 524 million (8% of the total world’s population) to nearly 1.5 billion in 2050 
(16% of the world’s population) (World Health Organization, National Institute of Aging 
& National Institute of Health, 2011; Cohen, 2003). In Canada, older adults are also the 
fastest growing age group. In 2011, the proportion of Canadian older adults aged 65 years 
and older was 5 million; one in seven was 65 years and over, and this number is expected 
to increase to 10.4 million older adults, one in four, which will make the older adults age 
group roughly one -quarter of the population in 2036 (Statistics Canada, 2011). 
With the rise in the older adult population, the incidence of cognitive decline is rapidly 
increasing as well as the risk of losing independence (quality of life), and the associated 
challenges both economically and socially are all expected to increase concomitantly. 
Severe cognitive decline and impairment such as dementia can cause devastating effects 
on both older adults and their families and can exert a significant financial strain on the 
health care system. So far, there are no therapies available to cure dementia (Massoud & 
Leger, 2011). However, pharmacological and non-pharmacological approaches can at 
least relieve symptoms and perhaps delay the progression of the disease. Thus, the 
successful development of cost-effective and efficient preventative strategies is extremely 
important since, if available, these strategies could prevent or delay the onset of cognitive 
decline and impairment and its severe effects on the lives of millions of people. As a 
result, devising strategies such as identifying modifiable risk factors to prevent cognitive 
decline and impairment and to maintain an independent elderly population is a priority. 
Diet is one important non-pharmacological approach to successful aging and in particular 
the aging cognitive status. Therefore, the impact of consuming dairy products on the 
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performance of various neuropsychological tests was investigated in a sample of non-
demented older adults living in London, Ontario, Canada.  
1.1 Statement of Purpose  
The aim of the present study was to determine the impact of consuming dairy products on 
cognitive performance in community-dwelling older adults. The study utilized dietary 
data and neuropsychological assessment data to address the following research questions. 
1.2 Research Questions 
This thesis explored three research hypotheses of the effect of dairy products on cognitive 
function.  
The first purpose of the present study was to investigate whether there is a significant 
difference in the mean cognitive test scores between people who consumed the 
recommended amount of dairy products (3 servings per day- according to Canada’s Food 
Guide (CFG) for both males and females aged 51+ years old) (Health Canada, 2011) and 
people who consumed less than the recommended amount of dairy products (1 or 2) 
servings per day. 
Hypothesis (H1): There is a significant difference in the mean cognitive test scores 
between people who consume the recommended amount of dairy products (3 servings per 
day) versus people who consume less than the recommended amount. 
The second purpose of the study was to explore whether there was an association 
between scores on cognitive tests and the levels of macronutrients and micronutrients 
found in participants’ dietary intake of dairy products. 
Hypothesis (H2): Performance on cognitive tests will be correlated with levels of 
saturated fat, vitamin D and calcium as derived exclusively from the dairy products 
consumed by older adults. 
The third purpose of the study was to explore whether there was an association between 
cognitive test scores and levels of macronutrients and micronutrients found in 
participants’ total dietary intake. 
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Hypothesis (H3): Performance on cognitive tests will be correlated with levels of 
saturated fat, vitamin D and calcium derived from older adults’ total dietary intake.  
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2 Literature Review 
2.1 Cognition 
2.1.1 Aging and Cognitive Domains 
As a result of the expected increase in the population of older adults worldwide and in 
Canada, it has become important to better understand the changes that accompany the 
aging process. Aging can have diverse effects on cognitive functions. With age, many 
older adults experience changes in their thinking abilities; for instance, they face 
difficulties in mathematical calculations, attention-requiring activities, and memory 
retention.  The scientific term for these mental abilities and processes is cognition. 
Cognition refers to the complex mental processes that enable humans to exert control 
over their environment and is critical for survival (Dye, LIuch, & Blundell, 2010). It 
includes domains such as memory (episodic, semantic, and working memory), language, 
attention, executive function, and processing speed. Most experts agree that preservation 
of cognitive ability, including language, memory, executive function (the ability to plan 
and carry out tasks) and attention well into old age is essential to live an independent life 
(Elias, 1998). However, cognitive decline is expected as a person ages, and has been 
reported across a variety of cognitive domains.  For example, age-related cognitive 
decline has been frequently reported in areas such as executive functioning, attention, 
processing speed, episodic memory, and visuo-spatial functioning (Reid & MacLullich, 
2006; Park, Lautenschlager, Smith, Hedden & Davidson, 2002; Salthouse, 1996; 
Verhaeghen & Cerella, 2002). For example, memory-related complaints increase with 
age, with up to 50% of adults aged 65-74 years, compared to 88% of older adults aged 85 
years and over, reporting having difficulties with memory (Reid & MacLullich, 2006). 
However, for other cognitive functions such as semantic memory (world knowledge) and 
implicit memory (previously experienced stimuli that do not require conscious or 
intended retrieval of encountered information such as riding a bicycle), cognitive function 
remains intact (Ackerman & Rolfus, 1999; Beier & Ackerman, 2001; Kemper & Sumner, 
2001).  
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2.1.2 Cognition between Normal Aging and Dementia 
Cognitive decline can be classified into three types. The first is age-related cognitive 
decline, which is normal cognitive decline that happens as part of a normal aging process 
and is generally mild and does not interfere with the ability to participate in daily 
activities (Anderson, Murphy, & Troyer, 2012; American Psychiatric Association, 1994). 
Second, mild cognitive impairment (MCI) involves a cognitive decline in memory and 
other cognitive functions beyond that normally expected in a person of the same age and 
years of education; however, it is not severe enough to cause lifestyle changes (Anderson 
et al., 2012). Third, dementia, specifically Alzheimer’s disease, is severe cognitive 
decline that can affect one or multiple domains such as memory, executive functioning, 
and/or language beyond that found in normal aging resulting in impediment of the 
person’s ability to live independently (American Psychiatric Association, 1994). 
According to the American Psychiatric Association (1994), age-related cognitive decline 
is an objective decline in cognitive functioning as part of the aging process but within 
normal limits given the person’s age. Whether age-related cognitive decline is a 
representation of a normal aging process, or expresses a distinctive clinical medical 
condition, or is eventually a continuum with dementia is still difficult to establish (Brayne 
& Calloway, 1988). It is vital to consider that people’s differences in cognitive decline 
form a continuum not an entirely discrete group, and that it is far from straightforward to 
separate non-pathological (age-related cognitive decline) from pathological cognitive 
decline (mild cognitive impairment and dementia). Of course, it is important to define 
people into groups such as mild cognitive impairment or dementia for treatment 
purposes; however, it is vital to recognize that people’s differences in cognitive decline 
can change from non-pathological (age-associated cognitive decline) to pathological 
(dementia) in old age (Deary et al., 2009).  
Severe cognitive decline (dementia) is expected to increase as the population ages.  For 
example, it is estimated that by 2050, 115 million people worldwide will be living with 
dementia/Alzheimer’s disease (World Health Organization, National Institute of Aging & 
National Institute of Health, 2011). In Canada, the prevalence of dementia will double as 
well to more than 1 million Canadians over the next 25 years (Naqvi, Liberman, 
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Rosenberg, Alston, & Straus, 2013). Older people affected by this disease will eventually 
need constant care and help with basic activities of daily living (ADL), creating a heavy 
economic and societal burden on the health care system. In 2010, the total worldwide 
costs of dementia exceeded 600 billion dollars, including informal care provided by 
family and others, social care provided by community care professionals, and the direct 
costs of medical care (World Health Organization, National Institute of Aging & National 
Institute of Health, 2011). In Canada, as in other parts of the world, the health and 
economic burden of cognitive decline is enormous. In addition to the personal losses 
experienced by people with severe cognitive decline, due to losing their ability to 
function independently, the financial costs to society are substantial. It cost Canada an 
estimated 33 billion dollars per year, including combined direct (medical) and indirect 
(lost earnings) costs in 2012, and it is projected to increase to $293 billion a year by 2040, 
putting a significant financial strain on the health care system (Alzheimer Society, 2012). 
Unless new and more effective interventions are found to treat or prevent this severe 
cognitive decline, its prevalence and the costs associated with it are expected to rise 
dramatically with the aging population. As a result, prevention of cognitive decline in 
older adults becomes an even higher priority, and making lifestyle changes such as diet 
modifications to slow or prevent cognitive decline and impairment will become more and 
more crucial. Thus, identifying non-pharmacological approaches through healthy lifestyle 
modifications may have the potential to prevent or slow down the deterioration of 
individuals’ cognitive function. There has been a tremendous amount of research on the 
development of effective dietary interventions that may help inhibit or ameliorate 
cognitive decline. Diet is one modifiable factor that is associated with the etiology of age-
related cognitive decline, and has been a topic of interest over the past two decades. 
Dietary intervention can be targeted as an appropriate intervention to optimize the 
cognitive function of an aging person (Crichton, Bryan, Murphy & Buckley, 2010). 
Whereas diet may not be useful to treat cognitive decline and impairment, it could be 
useful to enhance cognitive functions by preventing or ameliorating the severity of the 
cognitive decline and impairment. There are positive associations between cognitive 
function in older people and a number of nutrients, including antioxidants (vitamins C 
and E) (Engelhart et al., 2002a; Wengreen et al., 2007), omega 3 polyunsaturated fatty 
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acids (Gillette-Guyonnet, Secher, & Vellas, 2013), fruits and vegetables (Kang, Ascherio, 
& Grodstein, 2005; Ortega et al., 1997; Lee et al., 2001), and vitamin B complex 
(vitamins B6 and B12, and folate) (Morris, Schneider, & Tangney, 2006c). However, 
little attention has been paid to the potential impact that dairy products might have on 
cognitive function in comparison to other nutrients. Few studies have examined 
specifically the influence of dairy products (directly) on cognitive function and others 
have examined the impact of dietary intake in general with no particular focus on dairy 
products intake (indirectly) on cognitive function. Of the little conducted dairy research 
on cognitive function, there are some indications of positive correlation between dairy 
product intake and cognitive function (Crichton, Murphy, Howe, Buckley & Bryan 2012; 
Park &Fulgoni, 2013; Crichton, Elias, Dore & Robbins, 2012; Crichton, Murphy & 
Bryan, 2010, Ozawa et al., 2014). As a result, it would be valuable to assess directly and 
in more detail the impact of dairy products on cognitive function in community-dwelling 
older adults.  
2.1.3 Morphological Changes at the Brain Level  
There are normal changes that occur in the brain as part of the aging process: the most 
obvious is a steady decrease in brain size (brain atrophy). The brain undergoes normative 
structural changes in old age, although not uniformly across all brain areas (Raz & 
Rodrigue, 2006). Some of the brain lobes that show significant changes include the 
frontal lobe and the temporal lobe, while other lobes such as the parietal and occipital 
lobes remain relatively preserved across the lifespan (Anderson, Murphy, & Troyer, 
2012). The frontal and temporal lobes are most affected when the person ages and they 
decline at a faster rate, compared to other lobes such as parietal or occipital lobes. The 
frontal lobe shows notable changes with aging. At a structural level, there is evidence of 
atrophy in both the gray matter (the neuron cell body) and the white matter (the nerve 
fibers connecting different brain areas) (Anderson, Murphy, & Troyer, 2012). The decline 
in gray matter may reflect reductions in the number of cells (due to cell death) or may be 
a sign of neuronal shrinkage. The white mater changes reflect axonal abnormalities, and 
may result in slowed neurotransmission. It is plausible that these white matter changes 
may mediate the larger performance declines in tasks mediated by the frontal lobe that 
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accompanies healthy aging (Anderson, Murphy, & Troyer, 2012; West, 1996). It has been 
suggested that the myelinated fibers in this region are more susceptible to breakdown and 
this could affect the speed for relaying messages from one neuron to another in the brain. 
Thus, one of the most significant impacts of change in the white matter is a general 
slowing of the speed of thinking ability of an aged person (Anderson, Murphy, & Troyer, 
2012).  The temporal lobe, including the hippocampus, is important in retrieval and 
associating learned information over time, among many other cognitive functions 
(Anderson, Murphy, & Troyer, 2012). The cause of age-related shrinkage of this lobe 
includes some loss of neurons (neuronal atrophy or shrinkage) as well as a decrease in the 
size and number of branches of the existing neurons (Anderson, Murphy, & Troyer, 
2012). The hippocampus (an important region in forming vivid and detailed memory) 
tends to be under-recruited by older adults during both the encoding and retrieval phases 
of associative memory tasks, which often correlate with the older adults’ reduced 
performance on these tasks (Kensinger, 00; Cabeza, 2002). In addition to the structural 
changes of the brain with age, there are also chemical changes. Certain neurotransmitters 
such as acetylcholine and dopamine are important for communication between neurons 
and these decline with age as part of the aging process (Anderson, Murphy, & Troyer, 
2012). For example, the cerebral dopamine receptor density depletes with age, which 
plays a central role in regulating attention and in modulating response to contextual 
stimuli (Hedden & Gabrieli, 2004). In summary, several cognitive changes, such as 
atrophy in the frontal and temporal lobe neurons, alteration in the white matter, and 
reduction in acetylcholine and dopamine levels have been associated with age.  
2.2 Cognitive decline: Non-Dietary Risk and Protective Factors 
Several studies have suggested that there are lifestyle-related behaviors that may prevent 
the development of cognitive decline (Solfrizzi et al., 2011; Dye et al., 2012; Gao et al., 
2013). Table 1 summarizes some of the proposed risk and protective factors that may 
contribute to the deterioration of cognitive function as an individual ages. However, the 
exact mechanisms by which these factors contribute to the development of cognitive 
decline and impairment remain partially unclear due to the fact that one cannot perform a 
randomized controlled trial (RCT) and also the lack of homogenous exposure and 
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outcome measures (Williams et al., 2010).  
Table1: Non-Modifiable and Modifiable Risk Factors of Cognitive Decline and 
Impairment  
Non-modifiable risk factors Modifiable factors 
Advanced age 
Genetic 
     Family history  
     ApoE 4 
     Other Novel genes 
(listed at www.alzgene.org) 
 
Risk factors Protective factors 
Vascular and metabolic 
   Cerebrovascular disease  
(CBVD)/Stroke 
   Cardiovascular disease 
(CVD) 
   Diabetes Mellitus (DM) 
   Hypertension 
   Hypercholesterolemia 
   Obesity 
 
Psychosocial 
   Low education 
   Loneliness 
 
Nutrition and lifestyle 
   Saturated fatty acids 
(SFAs) 
   Homocysteine 
   High alcohol consumption 
   Smoking 
 
Other 
   Psychological 
stress/depression 
   Traumatic brain injury 
(TBI) 
   Respiratory disease  
   Inflammation 
 
 
Psychosocial 
   High education 
   Social network 
   Cognitive stimulation 
 
Nutrition and lifestyle  
   Mediterranean diet 
PUFAs (e.g. in vegetable 
and fish oils) 
   MUFAs (e.g. in olive oil) 
   Antioxidants (e.g. 
vitamins C and E) 
   Vitamins B12, B6 and 
folate 
   Coffee 
   Moderate alcohol/wine 
consumption 
   Physical activity 
 
Other  
   Anti-hypertensive drugs 
Statins 
   Hormone replacement 
therapy (HRT) 
   Non-steroidal anti-
inflammatory drugs 
(NSAIDs) 
Abbreviations: ApoE= Apolipoprotein E; MUFA= monounsaturated fatty acid; 
PUFA=polyunsaturated fatty acid 
Note. From “The Effects of Midlife Diet on Late-Life Cognition: An Epidemiological 
Approach” by Eskelinen, M., 2014, Publications of the University of Eastern Finland, 
Dissertations of Health Sciences, p.7. 
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2.2.1 Age and cognitive decline: It is well known that age is a risk factor for cognitive 
decline as it is more prevalent with aging populations (Brayne, 2007). Among individuals 
aged 60-64 years, the prevalence of dementia is around 1%, but beyond the age of 65, the 
prevalence of dementia increases exponentially such that up to 50% of 95 year olds are 
affected (Anderson et al., 2012).  
2.2.2 Alcohol and cognitive decline: Moderate alcohol consumption is associated with 
better cognitive performance and protective effects against cognitive decline and 
impairment than either abstinence or heavy drinking. This could be due to the protective 
effect of alcohol on cardiovascular and cerebrovascular health, which are considered 
major risk factors for cognitive decline (Ganguli, Vander Bilt, Saxton, Shen, & Dodge, 
2005). 
2.2.3 Smoking and cognitive decline: smoking, because of its relationship with 
cardiovascular disease, is a significant risk factor for cognitive decline and impairment. A 
dose-response effect is evident for the number of cigarettes smoked during one’s lifetime 
and the degree of cognitive decline (Nooyens, van Gelder, & Verschuren, 2008). 
2.2.4 Physical activity and cognitive decline: Cognitive decline is delayed or reduced in 
people who engage in physical activity. Individuals who walk more may experience less 
cognitive decline in later life. This is due to the fact that cardiovascular risk factors are 
known to play a role in the trajectory of cognitive decline in later life, and physical 
activity lowers these risk factors (Fratiglioni, Paillard-Borg, & Winblad, 2004). Research 
has shown that physical activity might enhance cognition as cardiovascular fitness 
increases cerebral blood flow and oxygen delivery to the brain, thereby increasing neuron 
formation and maintaining brain volume (Etnier, Nowell, Landers, & Sibley, 2006).   
2.2.5 Education and social class and cognitive decline: More years spent in formal 
education and higher social class are associated with less cognitive decline. Mechanisms 
could include increased “cognitive reserve” through educational and occupational 
trajectories, safer working and living environments, and access to better health care 
(Deary et al., 2009; Chodosh, Reuben, Albert, & Seeman, 2002). 
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2.3 Nutrition: Dietary Assessments and Recommendations 
2.3.1 Dietary Assessments 
There are several dietary measurement methods that can be used in clinical trials and 
epidemiological studies to collect dietary intakes from individuals. The most common 
ones are presented in Table 2. However, it is important to note that despite the various 
available dietary measurement methods, no single best method exists and diet 
measurement will always be accompanied by some degree of error (Beaton, 1994). 
Selecting an appropriate dietary method depends on such considerations as the research 
design, characteristics of the study participants, and available resources (e.g. skilled 
personnel, computer facilities, and finances) (Lee & Nieman, 2010). In addition, 
characteristics such as age, commitment and active participation as well as memory and 
literacy of the study participants all play a role in choosing the dietary measurement 
method (Lee & Nieman, 2010). Briefly, the methods can be divided into two categories: 
record (prospective) and recall (retrospective) (Gibson, 2005; Mahan & Escott-Stump, 
2008). Food records or food diaries collect information on current intake over one or 
more days (usually 1-7 days) (Gibson, 2005). There are two types of food intake records: 
weighed and estimated. A weighed food intake record is a quantified measure of food and 
beverage consumption by using scales, while estimated food intake record involves 
estimating the portion size by using household measures and/or a picture-based portion 
size booklet (Gibson, 2005; Mahan & Escott-Stump, 2008). All methods must be 
accompanied by specific data processing software to calculate the food and nutrients 
intakes, as well as by up-to-date food composition tables.  
Table 2: Dietary Assessment Methods  
Method Advantages Disadvantages 
Record methods-current intake 
Food record or diary -Daily recording at the time 
of food consumption 
-Can provide recorded 
information on quantity of 
food, how food is prepared, 
and timing of meals/snacks 
-Requires literacy skills of 
participants 
-Requires ability to 
measure/judge portion size; 
underreporting is common 
-Food intake may be altered 
-Sex differences exist 
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(women more competent) 
-High costs of coding and 
analysis 
Recall methods-past consumption 
24-hour recall -Quick 
-Easy 
-Inexpensive 
-Useful in clinical settings 
-Good reliability between 
interviewers 
-Relies on the short-term 
memory; in the elderly 
often unreliable 
-May not represent usual 
intake nor reflect nutrient 
intakes for populations 
- A tendency to over-and 
underreport 
-Selective forgetting (e.g. 
fat and alcohol)  
-Requires interviewing 
skills and comprehensive 
training of the interviewers  
Food frequency 
questionnaire 
-Easily standardized 
-Good overall picture of 
food intake; consists usually 
of 50-150 food items 
-Suitable for large 
populations 
-Inexpensive 
-Useful in studying the 
association of a specific 
food/foods and disease 
 
-Requires literacy skills 
-Requires knowledge of 
portion sizes 
-No meal pattern data, day-
to-day variation, longer- 
term periods of intake, nor 
quantity-estimation of 
specific nutrients 
-Researcher has to know 
well the current diet before 
being able to develop an 
appropriate questionnaire 
 
Dietary history -Good description of usual 
intake 
-Good for longitudinal 
studies 
-Observes seasonal 
variations 
-Difficult to standardize 
-Time-consuming (1-2 h) 
-High costs of analysis 
Note. From “The Effects of Midlife Diet on Late-Life Cognition: An Epidemiological 
Approach” by Eskelinen, M., 2014, Publications of the University of Eastern Finland, 
Dissertations of Health Sciences, p.11. 
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2.3.2 Nutrition recommendations in North America 
2.3.2.1 Macronutrient recommendations for older adults  
There are set guidelines for macronutrient and micronutrient recommended in North 
American populations, for example, the Acceptable Macronutrient Distribution Ranges 
(AMDR). AMDR are values of intake for energy sources that are associated with reduced 
risk of chronic diseases while providing adequate intakes of essential macronutrients 
(Institute of Medicine, 2002). AMDR is expressed as percentage of total energy or as 
percentage of total calories. It has a lower and higher end range. It shows that the 
incidence of chronic disease will increase if one consumes nutrients above the high 
boundary of the AMDR, while those who consume less than the lower boundary will 
increase the risk of consuming inadequate level of macronutrients essential for health 
(Thompson, Manore, & Sheeshka, 2007). According to AMDR, dietary carbohydrates 
should be between 45-64% of total energy intake, dietary protein from 10-35% of total 
energy intake, and dietary fat between 20-35% of total energy intake (Institute of 
Medicine, 2002).  However, the energy needs of older adults are lower than their younger 
counterparts. This is due to loss of muscle mass and lean tissue, a reduction in thyroid 
hormones, and a less physically active lifestyle (Thompson, Manore, & Sheeshka, 2007). 
For example, it is estimated that total daily energy expenditure decreases approximately 
10 calories each year for men and 7 calories each year for women aged 19 years and older 
(Institute of Medicine, 2002). This translates, for instance, to a woman who needs 2000 
calories (8370 KJ) at age 20 needing just 1560 calories (6900 KJ) at age 70. Some of this 
decrease is an inevitable response to the aging process, which can be delayed and 
minimized by staying physically active and consuming a diet high in nutrients to avoid 
weight gain. As for micronutrient intake, there are Dietary Reference Intakes (DRIs). 
According to these guidelines, it is recommended that the intake of saturated fatty acids, 
trans fatty acids and dietary cholesterol be as low as possible while consuming a 
nutritionally healthy diet (Health Canada, 2010). However, to reduce the risk for chronic 
diseases such as heart diseases (and consequently cognitive decline), it is recommended 
that total fat remain within the 20-35% of the total daily energy intake, with no more than 
10% of total energy intake from saturated fat and <300mg per day of cholesterol  
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(Thompson, Manore, & Sheeshka, 2007; National Institutes of Health, 2002).  
2.3.2.1 Micronutrient recommendations for older adults 
The vitamins and minerals of particular concern for older adults are calcium, vitamin D, 
and vitamin B12 (Thompson, Manore, & Sheeshka, 2007). As individuals age, the body 
undergoes changes that affect the amount of nutrients needed and the way that the body 
process them. For example, the requirements for calcium and vitamin D, both important 
for nerve and muscle function, are higher because of the reduced absorption of calcium 
from the gut, along with reduced production of the active form of vitamin D (which helps 
with calcium absorption) in older adult’s skin as a result of aging (Thompson, Manore, & 
Sheeshka, 2007). Therefore, it is critical that older adults consume foods that are high in 
calcium and vitamin D such as low fat cheese, milk, and yogurt. To ensure better health 
the dietary reference intake recommendations have recently increased from 15mcg/day 
for those aged 51-70 years old to 20mcg/day for ages 71+ years for vitamin D, and 
1000mg/day for males and 1200 mg/day for females aged 51-70 years to 1200mg/day for 
males and females aged 71+ years old for (Health Canada, 2010).    
In addition, vitamin B12 is another nutrient of concern for older adults. Older adults need 
to consume adequate amounts of vitamin B12 (cobalamin), vitamin B6 (pyridoxine), and 
folate as inadequate intake of these nutrients are associated with high levels of the amino 
acid homocysteine (HCy) in the blood. Elevated homocysteine levels are associated with 
an increased risk for cardiovascular, cerebrovascular, and peripheral vascular diseases, 
and consequently cognitive decline and impairment (Clarke et al., 2007; La Rue et al., 
1997). Accumulation of HCy, in the body has been found to result in oxidative stress, 
excitation toxicity in neurons, as well as increased DNA strand breakage and 
mitochondrial membrane damage (Kruman et al., 2000). Vitamin B12 is essential for 
neurological functioning as it is responsible for enhancing the growth and division of red 
blood cells (Watanabe, 2007). As a result, deficiency in this vitamin, which tends to 
affect a large proportion of older adults, is associated with serious health problems such 
as neurological defects, cognitive decline, and hyperhomocysteinemia, a risk factor for 
atherosclerosis, which in turn is a risk factor for cardiovascular diseases and cognitive 
decline later in life (Miller, 2003). Elevated inflammation and vascular disease markers, 
15 
 
such as homocysteine, are implicated in abnormal cognitive decline and dementia. 
Vitamin B12 deficiency could result from either a low dietary intake of important food 
sources such as dairy products or problems with its absorption in the intestines 
(Thompson, Manore, & Sheeshka, 2007). The symptoms of vitamin B12 deficiency 
include feelings of tiredness, difficulties with attention and memory retention, irritability, 
and depression. Treatment of this deficiency usually results in improvement in cognitive 
symptoms, including memory problems. A study involving healthy older adults showed 
that consumption of 3 cups of milk per day for 12 weeks increased vitamin B12 levels 
compared to the control group that did not receive milk supplementation (Barr et al., 
2000). Also, in a population-based sample of 1183 middle-aged men and women, dietary 
intake of vitamins B12 and B6 (pyridoxine) was positively associated with self-reported 
memory function of middle-aged men, and intakes at around the RDI were associated 
with better memory functioning for women (Bryan & Calvaresi, 2004). Thus, 
maintaining adequate dietary levels of B12 is essential for healthy brain aging through 
maintaining proper metabolism of HCy, without which the brain becomes more 
susceptible to oxidative damage and apoptosis and consequently cognitive decline and 
impairment.  
2.4 Dairy product consumption in North America 
Dairy products (milk, cheese, and yogurt) are rich sources of vitamin B12, vitamin D, 
calcium, and alpha-lactalbumin (whey protein). The latter results in bioactive peptides 
when partially hydrolyzed and in tryptophan and cysteine when fully hydrolyzed 
(Chatterton et al., 2006; Camfield, Owen, Scholey, Pipingas, & Stough, 2011) . These 
various dairy components have been identified as part of the underlying mechanisms that 
may help with cognitive functioning, either directly or indirectly. Directly, they work via 
enhanced synthesis of the neurotransmitter “serotonin”, which is important for the 
regulation of mood as well as cognitive function (Camfield, Owen, Scholey, Pipingas, & 
Stough, 2011). A fully digested α-lactalbumin protein results in tryptophan (precursor of 
serotonin and cysteine (precursor of glutathione) (Chatterton et al., 2006). By increasing 
the blood plasma level of tryptophan, there is greater transport of this amino acid across 
the blood-brain barrier, which results in enhanced serotonin synthesis in the brain 
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(Lehnert & Wurtman, 1993). Thus, raising brain serotonin level results in enhanced mood 
and cognitive function. This also results in increased neurogenesis that occurs following 
stress and the aging process (Jacobs, Van Praag, & Gage, 2000). In addition, serotonin 
help improve deficiencies and abnormalities in older adults’ cognitive function (Jouvet, 
1999). 
Indirectly, dairy components work via mediating effects on cardiometabolic health. 
Several studies have revealed that consumption of milk and other dairy products has a 
beneficial role on cardiovascular health by counteracting cardiometabolic risk factors 
associated with metabolic syndrome (Pfeuffer & Schrezenmeir 2007; Van Meijl, Vrolix, 
& Mensink, 2008). Metabolic syndrome is characterized as a cluster of cardiometabolic 
risk factors including waist obesity, high blood pressure (hypertension), dyslipidemia 
(hypertriglyceridemia and low high-density lipoprotein (HDL) cholesterol), and high 
blood sugar/glucose (diabetes) and insulin resistance. For example, whey protein has 
been found to be insulinotropic (Nilsson, Stenberg, Frid, Holst, & Bjorck, 2004). Milk 
peptides and calcium have also been found to reduce blood pressure (Nakamura, 
Yamamoto, Sakai, & Takano, 1995), and they can even reduce plasma (total cholesterol 
and low-density lipoprotein) cholesterol (Nagaoka et al., 2001). It is recommended that 
older adults aged 51 years and older consume 3 servings of dairy products daily (Health 
Canada, 2011). However, milk consumption has fallen over the past 20-25 years in many 
countries (Elwood, 2005). According to Garriguet (2007), a large proportion of 
Canadians, in all age groups, are not meeting their recommendations for dairy products. 
This is supported by the most recent per capita consumption survey indicating an average 
of 1.3 serving of dairy products per day. Two out of three Canadians are not consuming 
the minimum number of servings of milk per day due to excessive intake of caffeine, as 
well as frequent consumption of sweetened beverages and soft drinks (Garriguet, 2007; 
Weaver, 2010). Moreover, over 70% of those aged 50 years and older are not meeting the 
recommendation of 3 servings per day of dairy products (Garriguet, 2007). 
Dairy products are one dietary component receiving little attention in relation to cognitive 
function despite numerous studies confirming their beneficial role to cardiovascular 
health. In addition, research studies have positively associated these cardiometabolic risk 
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factors including hypertension (Qiu, Winblad, & Fratilioni, 2005), diabetes (Gregg et al., 
2005), dyslipidemia (Moroney et al., 1999), and obesity (Whitmer, Sidney, Selby, 
Johnston, & Yaffe, 2005) with increased risk of cognitive decline and dementia. Thus, the 
beneficial change in cardiometabolic health imparted by high dairy intake may be the 
primary mechanism by which dairy products (indirectly) reduce the risk of cognitive 
decline. The following are the current theories regarding the likely mechanisms of action 
by which dairy products’ individual constituents affect cognitive function directly. 
2.4.1 Dietary fat and cognitive health 
Fats are important constituents of the human diet due to their high-energy value (9kcal/g), 
but also because fat-soluble vitamins, such as vitamins A, D, E and K, and carotenoids 
(vitamin A precursors) play a critical role in the health and functioning of the human 
body (German &Dillard, 2006). Milk fat as a whole is comprised primarily of 
triglycerides, in addition to a small amount of phospholipids and sterols, namely 
cholesterol. Triglyceride is a fat molecule that is made of glycerol and three fatty acids. 
Absorption of the fatty acid component of the triglyceride molecule requires the 
hydrolysis of the triglyceride molecule into a glycerol molecule and free fatty acids 
(Bennion & Schedule, 2004). Fatty acids can be categorized into unsaturated fatty acids 
(UFA) and saturated fatty acids (SFA). Unsaturated fatty acids can be further categorized 
into monounsaturated fatty acids (MUFA) (found in olive oil) and polyunsaturated fatty 
acids (PUFA) (found in vegetable oil) (Bennion & Schedule, 2004). Milk fat contains 
almost 70% SFA, with myristic (14C) and palmitic acids (16C) combined accounting for 
almost 50% of long-chain saturated fatty acids (Jensen, 2000). Also, milk fat is a major 
source of short-medium saturated fatty acids such as butyric (4C), caproic acids (6C), 
lauric acid (12C) and stearic acids (18C) (Bennion & Schedule, 2004). The different 
chain length of SFA exerts varied biological effects and has a differential impact on 
cholesterol level. For example, myristic, palmitic and lauric acids are thought to have a 
large effect on cholesterol level, whereas butyric and caproic acids have neutral effect on 
human cholesterol levels (Visioli & Strata, 2014). Although a diet excessively rich in 
SFA is deleterious because of the increased risk of heart disease, it is important to note 
that the goal for overall dietary fats is not the elimination of fat, but the maintenance of a 
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healthy balance of SFA, MUFA and PUFA, and milk fat can contribute toward this 
balance (German & Dillard, 2006). Dairy products containing milk fat are major food 
sources of saturated fatty acids (SF), accounting for approximately 21% of total saturated 
fat intake in the U.S. diet (US Department of Health and Human Services Dietary 
Guidelines for Americans, 2010). As a result, only low-fat and fat-free dairy products are 
recommended to enhance healthy plasma lipid profiles to reduce the risk of 
cardiovascular diseases (Lichtenstein et al., 2006). However, reducing the amount of fat 
from dairy products only is not effective as other food groups can contribute to total fat in 
the human diet. High intake of SFA increases blood levels of total cholesterol and LDL 
cholesterol, which are considered a predictive risk factor for cardiovascular diseases 
(Thompson, Manore, & Sheeshka, 2007).  Certain SFA such as lauric (C12:0), myristic 
(C14:0), and palmitic acid (C16:0) have been considered hypercholesterolemic and were 
reported more than 40 years ago to raise total cholesterol and LDL-cholesterol levels (a 
well-established biomarker of cardiovascular disease risk) (Lichtenstein et al., 1998), 
whereas, stearic acid (C18:0) has little effect on cholesterol levels (Lichtenstein et al., 
1998). The concentration of these SFA in bovine milk varies widely and can range from 
11% to 54% by weight in milk fat (German & Dillard, 2006). That is why it is not 
effective to reduce all types of SFA as some of them can have little or no effects on total 
cholesterol level. Also, a causal relationship between the intake of saturated fatty acid and 
cardiovascular disease risk remains controversial (Siri-Tarino, Sun, Hu, & Krauss, 2010). 
Several prospective cohort studies have shown inconsistent evidence that higher intake of 
milk and dairy products, regardless of milk fat levels, are associated with an increased 
risk of cardiovascular disease (Elwood, Pickering, Givens, & Gallacher, 2010; 
Goldbohm, Chorus, Galindo Garre, Schouten, & van den Brandt, 2011). It is well known 
that a human diet containing SFA increases the plasma level of cholesterol and therefore 
can increase the risk of cardiovascular disease (Mensink, Zock, Kester, & Katan, 2003). 
In addition, the fatty acid composition is not altered when total fat is reduced because 
other food groups can also provide fat. Also, total fat reduction will contribute to reduced 
intake of polyunsaturated fatty acids (PUFA), and may result in the augmentation of the 
cholesterol-raising properties of certain saturated fatty acids, such as myristic fatty acid 
(in the case that PUFA falls below 5% of total calorie intake) (Hayes, Kohsla, Hajri, & 
Pronczuk, 1997). Many factors are associated with the variations in the amount and 
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composition of the fatty acid components in bovine milk: animal origins (related to breed 
and selection), stage of lactation, mastitis and ruminal fermentation, or feed-related 
factors such as fiber and energy intake and seasonal and regional effects (Jensen, 2000; 
Jensen, 2002).  Although SFA constitute a large proportion of milk fat, bovine milk 
contains a mixture of other components, such as lipids, protein, and micronutrients, many 
of which, when consumed separately or as components of dairy products, have shown 
favorable or neutral effects on outcome measures of cardiovascular disease risk 
(Tremblay & Gilbert, 2009; Soedamah-Muthu et al., 2011). For example, there are 
different constituents in dairy products that have beneficial health effects on metabolic 
syndrome, a risk factor for cardiovascular disease and cognitive decline later in life. For 
example, whey protein has been found to be insulinotropic (Nilsson et al., 2004). Other 
examples are milk peptides and calcium, which have been found to reduce blood pressure 
(Nakamura et al., 1995) and plasma cholesterol (Nagaoka et al., 2001). The possible 
mechanism by which calcium can affect plasma cholesterol levels is via fat absorption 
inhibition in the small intestine (Denke, Fox, & Schulte, 1993), reducing both total 
cholesterol and LDL cholesterol (bad cholesterol) while increasing HDL cholesterol 
(good cholesterol) (Van Meijl, Vrolix, & Mensink, 2008). As a result, consumption of 
dairy products is inversely associated with hypertension, diabetes, and 
hypercholesterolemia, which are considered components of metabolic syndrome as well 
as risk factors for cardiovascular diseases and cognitive decline later in life.  Thus, 
reducing the consumption of dairy products due to its fatty acid content may have a 
negative impact, as other components in dairy products have a positive impact on the 
wellbeing of an individual. Also, the association between SFA and cardiovascular 
diseases risk depends mainly on the length of the fat and whether it is naturally present in 
foods or added from industrially produced sources (hydrogenated). Short-chain fatty 
acids (SCFA) and medium chain fatty acids (MCFA) comprise approximately 10% of 
total fatty acids in milk by weight and are generally associated with no effect or a 
beneficial effect on blood lipids profile (Zaripheh & Miller, 2008). Despite 
recommendations of lowering saturated fatty acids in human diet, several studies support 
the role of these dietary fatty acids in enhancing HDL metabolism. Researchers have 
investigated the impact of reduction of total fat and saturated fatty acids on HDL 
metabolism in a group of multiracial, young and elderly men and women. Participants 
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consumed 3 different diets, each for 8 weeks: 34.3% total fat and 15% saturated fat; 
28.6% total fat and 9% saturated fat; and 25% total fat and 6% saturated fat. HDL 
metabolism decreased in a stepwise fashion after the reduction of total fat and saturated 
fat (Berglund et al., 1999).  
Literature has shown mixed associations between SFA in dairy products and cognitive 
function. Some studies have shown negative associations, and others have shown no 
associations. In a population-based prospective study on 1449 individuals aged 65-80 
years, older adults using moderate amount of fats from spreads and milk products had a 
decreased risk of developing dementia compared to individuals who use little or no fats at 
all (Laitinen et al., 2006). This indicates that moderate intake of fat in the diet may be 
beneficial. However, the type of fat in the diet should be taken into consideration too. In 
the same study, moderate intake of saturated fatty acids were associated with increased 
risk of dementia, while moderate intake of PUFA and MUFA were actually protective 
(Laitinen, et al, 2006). These associations were seen only among the Apo E epsilon 4 
group (gene responsible for dementia) even after adjusting for this factor (Laitinen et al., 
2006). In addition, the study showed that higher intake of SFA from milk products and 
spreads were associated with poorer global cognitive function and prospective memory, 
while higher intake of polyunsaturated fatty acids were associated with better semantic 
memory (Laitinen et al., 2006). In a French epidemiological cohort study to determine the 
potential long-term impact of dietary habits on age-related cognitive decline among 4809 
female older adults, cognitive decline was associated with lower intake of animal fats, 
and higher intake of dairy fats and vitamin A (Vercambre, Bortron-Ruault, Ritchie, 
Clavel-Chapelon, & Berr, 2009). In this study, participants consumed 70% of animal fat 
as butter and the intake was generally low with 95% of the women consuming less than 6 
grams per day (Vercambre et al., 2009). As a comparison, 90% of the population 
included in the Chicago Health and Aging Project consumed more than 16 grams of 
animal fat/day (Morris, Evans, Bienias, Tangney, & Wilson, 2004). The latter study 
concluded that diets high in SFA (16g of saturated fat) are associated with cognitive 
decline in older adults, whereas there was no association between the intake of animal fat 
and cognitive function in the French study. This could be due to the fact that the level of 
SFA (6g) in this study was below the level of which could be detrimental to cognitive 
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function. Also, in 2012, a randomized, two-way crossover dietary intervention trial 
examined the effect of high intake of reduced-fat dairy products on cognitive function. 
Fifty-nine overweight or obese individuals aged 18-75 years old, whose usual dairy 
product intake was low (2 servings/day) were randomized to either high dairy (4 
serves/day) or low-dairy (1 serves/day) treatment groups, and crossed over to the 
alternate diet after 6 months. Participants were tested at the end of each 6- month diet 
period on multiple measures of cognitive functions, including memory, information 
processing speed, executive functioning, attention, and abstract reasoning. In the 38 
participants who completed the trial, spatial working memory performance was 
marginally better following 6 months of consuming a high dairy products diet compared 
with a low dairy product diet (Crichton, Murphy, Howe, Buckley & Bryan, 2012). 
Another study involved a retrospective cross-sectional analysis using data from food 
frequency questionnaires on 432 men and 971 women, aged 39-65 years old. It 
investigated the association between consumption of dairy products and cognitive 
function, assessed by Cognitive Failures and Memory Functioning questionnaires. 
Results indicated that consumption of low-fat yogurt was associated with better memory 
recall in men only. Also, consumption of whole fat dairy products, including ice cream 
and cream (high in saturated fat) were associated with increased depression and poorer 
memory functioning (Crichton, Murphy & Bryan, 2010) 
Other studies have examined saturated fat from the total diet as opposed from dairy 
products only, and this literature has also shown mixed results. Some studies have shown 
a negative association and others have shown no association at all. For example, a study 
from Spain assessed the relationship between dietary intake and global cognitive 
functions using the Mini Mental State Examination and the Pfeiffer’s Mental State 
Questionnaire (PMSQ) in 260 community-dwellers who were mentally healthy 
individuals, aged 65-90 years old. Subjects with adequate scores in the MMSE (>28 
points) had lower intake of SFA, MUFA, and cholesterol (Ortega et al., 1997). However, 
whereas this study included other macro and micronutrients assessments, it did not 
include TFA intake. The Chicago Health and Aging Project followed 3718 subjects aged 
65 years old for over six years and evaluated their dietary intake with a 139-item FFQ. 
Cognitive change was measured at 3 and 6 year follow-ups with the East Boston Memory 
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Test (EBT) of immediate and delayed recall, the MMSE and the Symbol Digit Modalities 
test for perceptual-motor speed (SDMT). Results show that a diet high in saturated and 
trans fats may be associated with cognitive decline in older adults (Morris et al., 2006).  
This is supported by another study by The Cardiovascular Risk Factors, Aging and 
Dementia  (CAIDE) longitudinal study in Finland examined the association between 
cognitive health and diet. A population of 1449 people aged 65 to 80 years was followed 
for a total average of 21 years. An FFQ test was used for dietary assessment. Evaluation 
of cognitive status through the assessment of cognitive and executive global functions, 
memory, and psychomotor skills were conducted. Results show that abundant saturated 
fat at midlife was associated with poorer global cognitive function and prospective 
memory after adjusting for confounders. In contrast, high intake of PUFA was associated 
with better semantic memory. Furthermore, frequent fish consumption was associated 
with better global cognitive function and semantic memory. Higher PUFA-SFA ratio was 
also associated with better psychomotor speed and executive function (Eskelinen et al., 
2008). Also, a cross-sectional population-based study among 1613 adults aged 45-70 
years old examined dietary intake and cognitive function. Dietary intake was assessed via 
a self-administered food frequency questionnaire while cognitive function was assessed 
via neuropsychological tests including the visual (verbal) learning test, the Concept 
Shifting task, an abbreviated Stroop Color-Word test, the Letter Digit Substitution test, 
and a Category Fluency test. Results show that fatty fish and marine omega -3 
polyunsaturated fatty acids (PUFA) consumption was associated with a reduced risk of 
cognitive dysfunction while the intake of cholesterol and saturated fat were associated 
with increased risk of impaired cognitive function in this population group (Kalmijn et 
al., 2004). However, a three-year long prospective study examined the effects of dietary 
fatty acids on cognitive function in 482 women, failed to show any association between 
saturated fatty acids and cognitive function. Dietary intake was assessed with food 
frequency questionnaire while cognitive function was evaluated with various tests 
including Consortium to Establish a Registry for Alzheimer’s disease (CERAD), word 
list learning constructions, and word fluency tests. Results showed no association 
between cognitive function and intake of saturated fat, trans fat, or dietary cholesterol 
intake. MUFA intake was associated with lower cognitive decline, particularly in the 
visual and memory domains (Naqvi et al., 2011). 
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On the other hand, other studies have shown a positive association between dairy 
products consumption and cognitive function and longevity, without taking into account 
the fat level of the dairy products. For example, a cross-sectional study by Crichton et al. 
(2012) examined the association between dairy and cognition, based on data from 972 
adults aged 23-98 years from the community-based Maine-Syracuse Longitudinal study. 
The results demonstrated a significant association between the self-reported frequency of 
consumption of dairy products and cognitive function, assessed by a battery of eight 
cognitive tests. Highest scores for all cognitive tests were observed for high dairy product 
consumers: executive function, scanning and tracking, global and visual-spatial memory 
and organization, MMES, and verbal memory were better when compared with those 
who never or rarely consumed dairy products. However, the study did not account for the 
fat content of dairy products (Crichton, Elias, Dore & Robbins, 2012). This is supported 
by a 17-year longitudinal prospective population-based cohort study that examined the 
effects of milk and dairy intake on the development of dementia, especially Alzheimer’s 
disease in 1081 cognitively healthy Japanese older adults aged 60 years and older. Milk 
and dairy intake were estimated using a 70-item semi-quantitative food frequency 
questionnaire while cognitive function was assessed using the Hasegawa Dementia Scale 
or MMSE. Results show that higher intake of milk and dairy products were associated 
with lower incidence of all-cause dementia, especially Alzheimer’s disease and vascular 
dementia (Ozawa et al., 2014). Other studies have shown a positive correlation between 
longevity and dairy product consumption in older adults. A cross-sectional study 
investigated the relationship between dietary patterns and longevity in 104 centenarian 
(>100 years old) Japanese subjects. Dietary intake was assessed via a 3-day food intake 
record recorded by caregivers while cognitive function was assessed via a classified 
semi-quantitively scale into 5-categories ranging from (0-normal, 0.5- subnormal, 1-mild 
demented, 2- moderately demented, and 3- severely demented). Results showed that 
individuals with a dietary preference for dairy products tended to have greater longevity 
compared to the other dietary patterns in centenarian individuals (Shimizu et al., 2002). 
Also, in a 5-year cohort study among 162 self-sufficient, healthy older adults aged 65 
years and older residing in an elderly home in Rome, Italy, the relationship between 
specific food groups and nutrients and overall 5-year survival were assessed. Dietary 
intake was measured via a validated, semi-quantitative food frequency questionnaire. 
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Results showed that frequent consumption of citrus fruit, milk and yogurt, low 
consumption of meat, and high intake of vitamin C, riboflavin and linoleic acid is 
associated with longevity (Fortes et al., 2000).  
2.4.2 Dietary calcium and cognitive health 
Approximately 53% of daily nutrient intake of calcium is contributed by the consumption 
of dairy products in a typical Canadian diet (Agriculture and Agri-Food Canada, 2009). 
Calcium is an important mineral that is required in amounts greater than 100 mg per day 
in the human diet (Thompson, Manore, & Sheeshka, 2007).  Dairy products are the most 
common source of calcium in the Canadian diet, with one cup of plain yogurt and one 
cup of 2% milk contributing 450 mg and 300mg of calcium, respectively (Thompson, 
Manore, & Sheeshka, 2007). If dairy products are excluded from the diet, then it is 
difficult to meet the recommended daily intake (RDI)-adequate intake of calcium, which 
is 1200mg/day for males and females aged 50 years and older (Thompson, Manore, & 
Sheeshka, 2007). Older adults have a higher need for calcium; however, their ability to 
absorb calcium diminishes with age due to their reduced intestinal capacity (only 25%) to 
absorb calcium (Thompson, Manore, & Sheeshka, 2007). This change in calcium 
absorption with age has been taken into account by increasing the recommendation to 
1200mg/day, compared to the 1000 mg/day for adults aged 19-50 years old (Thompson, 
Manore, & Sheeshka, 2007). Calcium is critical for normal transmission of nerve 
impulses. It enters nerve cells and stimulates the release of molecules called 
neurotransmitters, which conduct nerve impulses from one neuron to another. Therefore, 
calcium deficiency inhibits the ability to transmit messages between neurons (Thompson, 
Manore, & Sheeshka, 2007). This is why a person can experience convulsions when 
blood calcium levels fall dangerously low (Thompson, Manore, & Sheeshka, 2007). 
However, in the case that a person’s calcium needs are high, the body will generally 
increase its absorption rate from the small intestine. However, as adults get older, their 
small intestine capacity to absorb calcium diminishes as part of the aging process along 
with their higher need of calcium. These individuals, in turn, will turn to calcium 
supplements to fulfill their higher need for calcium than can be obtained in a balanced 
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diet. This can lead consequently to various health conditions, such as mental confusion 
(Thompson, Manore, & Sheeshka, 2007).  
Hypercalcemia, or high serum levels of calcium, usually due to supplement use, is a 
disease condition in which serum (blood) calcium levels reach abnormally high 
concentrations (Thompson, Manore, & Sheeshka, 2007). This abnormal serum calcium 
level is associated with a cognitive decline in older adults (Schram et al., 2007). In 2007, 
one prospective cohort study of two independent, population-based studies, the 
Rotterdam study and the Leiden 85-plus study, have shown that high serum calcium 
levels are associated with a faster decline in cognitive function over the age of 75 years 
old (Schram et al., 2007). In the Rotterdam study, high serum calcium levels were 
associated with worse global cognitive function on the MMES and a faster rate of 
cognitive decline during 11 years of follow-up in older adults aged 75 years and over. In 
the Leiden 85-plus study, high serum calcium levels were also associated with worse test 
scores on the MMES and this held true for the specific cognitive domains that were 
tested: attention, psychomotor speed, and memory (Schram et al., 2007). In these two 
sub-studies, the authors did not mention the reason for high serum calcium levels, which 
could be either from calcium supplements use or disease conditions. The possible 
mechanism led to the observed association between serum calcium level and cognitive 
decline through calcium dysregulation. Calcium dysregulation or disrupted calcium 
homeostasis, plays a role in the pathophysiology of cognitive decline or dementia 
(Tolppanen, Williams & Lawlor, 2010). Calcium ions can diffuse easily through the 
blood brain barrier. Serum calcium levels are directly associated with the calcium levels 
in the cerebrospinal fluid in the brain or extracellular calcium levels in the brain 
(Tolppanen, Williams, & Lawlor, 2011). High calcium levels in the brain activate 
calcium sensor receptors, enhancing calcium influx into neurons, and leading to calcium 
overload and subsequently neuronal death (Breitwieser & Gama, 2007). Numerous 
studies have demonstrated that elevation of calcium levels in the neurons ultimately lead 
to neuronal cell death, and as a result, it is well known that maintaining serum calcium 
levels within a narrow limit within individuals is important in preventing cognitive 
decline and dementia (Schram et al., 2007). In summary, these research studies have 
suggested that high serum calcium levels due to supplement use is associated with greater 
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cognitive decline in older adults (Schram et al., 2007; Tilvis et al., 2004). While 
consuming too many calcium supplements can lead to toxicity and even death 
(Thompson, Manore & Sheeshka, 2007), consuming more than the recommended intake 
of calcium from dietary sources does not lead to toxicity as excessive dietary calcium can 
not be absorbed from the small intestine and will end up excreted in feces (Thompson, 
Manore & Sheeshka, 2007).  
Numerous studies have shown a positive association between dietary intake of calcium 
and cognitive function. For example, in a cross-sectional and a short-term prospective (9 
months) cohort study on active and mentally healthy community dwellers (n=187) over 
65 years of age in Portugal, researchers investigated the association between the 
adequacy of dietary intake of both calcium and omega-3 PUFA and cognitive function. 
Dietary intake was assessed using a 3-day food intake record, while cognitive function 
was assessed using the MMSE. Results showed that diets high in calcium are related to 
improvement in cognitive function, while high intake of omega-3 PUFA might prove to 
be beneficial (Velho, Marques-Vidal, Baptista, & Camilo, 2008). This is also supported 
by another cross-sectional study on cognitive healthy (n=449) community- dwellers aged 
60 years and older in Korea, which examined the association between dietary intake and 
cognitive function. Dietary intake was assessed using a 24-hour recall, while cognitive 
function was assessed using the MMSE. Results showed that a diet with low intake of 
calcium and dairy products was associated with lower cognitive test scores (Lee et al., 
2001).  Lastly, a 17-year long prospective population-based cohort study, examined the 
effects of milk and dairy intake on the development of dementia, especially Alzheimer’s 
disease, on 1081 cognitively healthy Japanese older adults aged 60 years and older. Milk 
and dairy intake was estimated using a 70-item semi-quantitative food frequency 
questionnaire while cognitive function was assessed using the Hasegawa Dementia Scale 
or the Mini-Mental Status Examination (MMSE). Results showed that higher self-
reported dietary intake of potassium, calcium and magnesium were associated with lower 
incidence of all-cause dementia, especially Alzheimer’s disease and vascular dementia 
(Ozawa et al., 2012). Also, a cross-sectional study was conducted on 240 elderly 
individuals (120 institutionalized and 120 free living) selected randomly from institutions 
and from different community sites in Alexandria, Egypt. The purpose of the study was 
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to assess the nutritional status, measured using 24-hour recall for 3 consecutive days of 
those living in institutions and those living independently in the community. Total daily 
energy intake, vitamin A and calcium (the nutrients least adequately supplied in the 
elderly diets) were found below the recommended dietary allowance for all subjects, with 
lower intake among free-living, compared with institutionalized individuals (Shabayek & 
Saleh, 2000). According to the research study results, this lower intake is due to the fact 
that free-living subjects had lower intake of calcium- rich food, such as milk and cheese, 
compared to institutionalized individuals, who were served milk and its products on daily 
basis at both meals and snacks (Shabayek & Saleh, 2000). Also, the study showed a low 
intake of vitamin A (important for enhanced cognitive function) among free-living 
compared to institutionalized individuals. This may be due to the low intake of fresh 
vegetables-rich in carotene, and low- fat dairy products such as milk and yogurt, which 
were mainly consumed by elderly subjects (Shabayek & Saleh, 2000).  This study 
indicated that community-dwellers in Egypt had lower dietary intake of calcium because 
they consumed less dairy products (rich sources of calcium) compared to institutionalized 
individuals. This indicates that dairy products are rich source of calcium and that 
community-dwelling older adults usually consume less than the recommended, which is 
in line with previous research studies. Thus far, research has shown that higher dietary 
intake of calcium is associated with improved cognitive function. 
2.4.3 Dietary vitamin D and cognitive health  
Vitamin D (calciferol) is a fat-soluble seco-steroid synthesized in skin (as hormone) or 
ingested with food (as vitamin) (Kalueff & Tuohimaa, 2007). Vitamin D is biologically 
inactive; however, it undergoes bioactivation by double hydroxylation in the liver and 
kidney, leading to the formation of 1,25-dihydroxyvitamin D, the main biological active 
form of vitamin D (Kalueff & Tuohimaa, 2007). Vitamin D crosses the blood- brain 
barrier and binds to vitamin D receptors in the brain. Vitamin D receptors and the enzyme 
responsible for formation of the active vitamin in the human brain, 1 alpha hydroxylase, 
are widespread in both brain neurons and glial cells within brain regions critical for 
cognition (Kalueff & Tuohimaa, 2007). This indicates that, as vitamin D is a fat-soluble 
vitamin, it can cross the blood- brain barrier. It is also the likely mechanism by which 
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vitamin D might have an effect on cognitive function. Beyond the age of 50 years, the 
need for vitamin D increases. It is estimated that we experience a four-fold decrease in 
our capacity to synthesize vitamin D from the sun by the time we reach 65 years of age 
and older (Thompson, Manore, & Sheeshka, 2007). Thus the adequate intake (AI) of 
vitamin D for men and women aged 50-70 years old is 10 µg/day, and the AI increases to 
15 microgram per day for adults aged 70 years and older. Most foods naturally contain 
very little vitamin D. Thus, our primary source of this vitamin in the diet comes from 
fortified milk. Due to high vitamin D insufficiency in the Canadian population, the 
government has proposed changes to both the levels of vitamin D added to foods, and the 
type of foods fortified. For example, currently, cow’s milk and goat’s milk have 
approximately 53 IU (1.3microgram) of vitamin D per 100 ml, but yogurt, buttermilk, 
cottage cheese, and most cheeses are not fortified with vitamin D (Thompson, Manore, & 
Sheeshka, 2007). Several studies have shown a positive association between lower 
vitamin D level and lower cognitive function in older adults. In a population-based, cross-
sectional study on 3369 European men aged 40-79 years, researchers have linked low 
serum 25-hydroxyvitamin D levels with slower processing speed on the Digit Symbol 
Substitution Test (DSST) cognitive test (Lee et al., 2008). Similar results were shown in 
another cross-sectional study on 3325 older adults aged 65 years and older which linked 
vitamin D deficiency with increased odds of cognitive decline and poor sustained 
attention, but not memory or visuospatial ability (Liewellyn, Lang, Langa, & Melzer, 
2011). Similarly, low levels of biomarker 25(OH) of vitamin D in homebound older 
adults in Boston were associated with poor executive functioning and processing speed 
but not memory (Buell & Dawson-Hughes, 2009). The study indicated that a low level of 
vitamin D is associated with lower cognitive decline. However, it is important to consider 
that the study did not account for whether this lower level was related to diet or 
supplements use or just not getting enough amount of sun exposure. Another study 
considered supplement use. A population-based cross-sectional study on 5596 female 
community-dwelling older adults in France, with a mean age of 80 years and free of 
vitamin D supplements, has shown that women with inadequate weekly dietary intake of 
vitamin D (5 microgram/day or 35 microgram/week) were associated with a lower score 
on Pfeiffer Short Portable Mental State Questionnaire (SPMSQ), a test for global 
cognitive function (Annweiler, Schott, Rolland, Blain, Hermann, & Beaucher, 2010).   
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On one hand, several mechanisms have been proposed to explain how vitamin D 
deficiency may increase the odds of cognitive decline. One of the mechanisms is that 
vitamin D is involved in the metabolism of several neurotransmitters in the central 
nervous system (CNS). Such neurotransmitters include, but are not limited to 
acetylcholine, dopamine, serotonin and gamma-aminobutryic acids (Kalueff & 
Tuohimaa, 2007).  Also, vitamin D may exert its neuroprotective role through its 
antioxidative properties, which in turn can stabilize cognitive functioning and prevent the 
onset of neurodegenerative diseases such as dementia (Kalueff &Tuohimaa, 2007). On 
the other hand, the exact mechanism by which dietary intake of vitamin D influences 
cognitive functioning is still unclear. It has been proposed that older women with poor 
cognition and loss of autonomy usually eat nutrient-poor foods, with subsequent 
inadequate dietary intake of vitamin D (Annweiler et al., 2010). Alternatively, a low 
vitamin D intake might be surrogate for other nutrient abnormalities, which could result 
in cognitive decline (Annweiler et al., 2010). According to the same study, disability is 
often seen among older women with cognitive impairment and inadequate dietary intake 
of vitamin D, compared to those with normal cognitive functioning and those taking the 
recommended dietary intake of vitamin D (Annweiler, et al., 2010). A cross-sectional 
study was conducted on 69 free-living urban healthy Italian elderly people aged  70-89 
years. Dietary analysis over 3 days before study entry and observed nutrient intake were 
compared with the Italian Recommended Dietary Allowance (RDA). Cognitive function 
was assessed using the MMSE. Results showed a significant negative correlation between 
dietary intake of vitamin D and poor performance on cognitive tests. This inverse 
relationship is due to low mean intake (below RDA) for calcium, vitamin D and folate. 
This inadequacy between the observed intake of those nutrients in this age group and the 
RDA was the result of low consumption of milk and by-products, fish, fruits and 
vegetables containing vitamin D (Rondanelli, Trotti, Opizzi, & Solerte, 2007). A 13-year 
population-based study in France looked at cognitively healthy adults aged 35-60 years 
and examined the association between midlife dietary intake of vitamin D and subsequent 
performance. Dietary intake was assessed using computerized 24-hour dietary records on 
randomly assigned days for a total of 6 records per year. Cognitive function was assessed 
13 years later with a comprehensive neuropsychological test battery that assessed:  
episodic memory using the RI-48 cued recall test (consisting of a list of 48 words divided 
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into 12 categories); semantic memory using the semantic fluency task (consisting of 
naming as many animals as possible); short-term memory using the forward and 
backward digit span test; and executive function using the Trail Making test. Results 
show that neither of these domains were associated with midlife dietary intake of vitamin 
D. However, the study did show a significant and positive association between midlife 
dietary intake of vitamin D and the forward digit span task measuring short-term 
memory. This indicates that dietary intake of vitamin D might have different effects on 
various cognitive domains (Andreeva et al., 2014).   
2.5 Cheese consumption 
In a state-wide survey of 1056 older adults aged 69 years in Albama, intake of cheese was 
found to be inversely correlated with cognitive decline (Rahman, Baker, Allman & 
Zamrinin, 2007). Study participants who ate cheese at least once a week were more than 
40% less likely to have cognitive decline than those who ate cheese less than once a week 
or never (Rahman, Baker, Allman & Zamrinin, 2007). The potential mechanism by which 
cheese consumption may affect cognitive function is through vitamin A (retinol), an 
antioxidant, or tyramine. Tyramine is an amino acid found in many cheeses. It is a 
precursor of major neurotransmitters (such as dopamine and norepinephrine) that play a 
role in cognitive functioning through anti-amnestic actions (Izquierdo & Dias, 1983). 
Another possible mechanism that may explain the effect of cheese on cognitive 
functioning involves the process of cheese aging. During cheese aging, bioactive peptides 
are formed which could have a beneficial effect on memory. These compounds need to be 
small to cross the blood brain barrier in the brain (Ortego et al., 1997; Wu, Ying, & 
Comez-Pinilla, 2004)). A single serving of aged cheese provides a high amount of certain 
proteins, lipids, vitamins and minerals, which continuously replenish the central nervous 
system (CNS). For instance, cheese provides specific amino acids such as cysteine that 
are important for glutathione production during periods of inflammatory stress. This 
amino acid allows the CNS to regulate inflammation and maintain homeostasis in the 
brain. Also, cheese provides lipids to the CNS, which allows neuronal cells signaling to 
function optimally as lipids play important roles in the synthesis and fluidity of the nerve 
cell membrane, synaptic plasticity and neuronal regulations (German & Dillard, 2006). 
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This could be the secondary mechanism of action of cheese on cognitive function (Park 
& Fulgoni, 2013). A study using a cross-sectional approach drew on data from the 
National Health and Nutrition Examination Surveys (NHANES 1988-1994 and 1999-
2002), and set out to determine the potential relationship between intake of dairy products 
(total dairy products, milk and cheese) and cognitive function in adults aged 60 years and 
older (Park &Fulgoni, 2013). In the first dataset, a story recall was used as the only test of 
cognitive functions (attention and delayed verbal memory). However, in the later dataset 
(NHANES 1999-2002), response speed, sustained attention, visual spatial skills and 
associative learning and memory were assessed using the digit-symbol substitution test 
(DSST). In both datasets, an in-person 24-hour dietary recall was obtained from the 
participants. The analyses showed that consumers of dairy products were associated with 
a higher score on the story recall test and the digit-symbol substitution test when 
compared with non-consumers. Even among groups, cheese consumption (high in 
saturated fat) showed significantly higher cognitive scores in comparison to milk 
consumption (Park & Fulgoni, 2013). This indicates that cheese consumption might have 
an effect on cognitive function.  
2.6 Yogurt consumption 
Yogurt, a fermented milk product, is a nutrient-dense food. It is abundant in calcium, 
zinc, B-vitamin, and probiotics (El-Abbadi, N., Dao, M., & Meydani, 2014). A 100-gram 
serving of plain low-fat yogurt contains 0.56 mg vitamin B12, 183 mg of calcium among 
many other dietary minerals and vitamins (USDA, 2013). Yogurt is also a good source of 
protein and it may be supplemented with vitamin D and additional probiotics, which are 
associated with a range of beneficial health outcomes at the level of musculoskeletal, 
immune, cardiometabolic, and cognitive systems. Research has shown that consuming 
yogurt (an average of 2.3 servings yogurt/week) is associated with a greater adherence to 
healthy dietary habits, such as eating fruits, vegetables, nuts, fish, and whole grains 
(Wang, Livingston, Fox, Meigs, & Jacques, 2013). These results further show that yogurt 
consumers have a significantly reduced prevalence of nutrient deficiencies for riboflavin, 
vitamin B12, calcium, magnesium, and zinc (Wang, Livingston, Fox, Meigs, & Jacques, 
2013). There is limited research on the influence of yogurt on cognitive function and 
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long-term mental health. This is why it is an important area for future research to explore, 
as yogurt is a rich source of vitamin B12 due to evidence of its anti-inflammatory effects 
that may be protective against cognitive impairment. A longitudinal study by Vercambre 
et al (2009) was conducted on French women born between 1925 and 1930 to examine 
the relationship between dietary habits and age-related mental health. The study showed 
that cognitive health and instrumental activities of daily living declined significantly with 
lower concentrations of riboflavin, vitamin B6 and vitamin B12. This result was 
supported by another cross-sectional study conducted in Australia by Crichton et al. 
(2010), on 432 men and 971 women, aged 39-65 years old. Results indicated that 
consumption of low-fat yogurt was associated with better memory recall in men only 
(Crichton, Murphy, & Bryan, 2010). 
In summary, the above research shows inconclusive results from studies regarding the 
impact of dairy products on cognitive function. This is due to several methodological 
issues that need to be taken into consideration. First, only a small number of studies have 
investigated the potential role of dairy products alone on cognitive function; most studies 
included other food groups. Second, some studies had a wide age range (e.g. 20-90 years 
of age), were not limited to older adults, and had a highly disproportionate number of 
participants between males and females. Third, dairy intake and total dietary intake were 
self-reported. Also, the researchers did not account for the fat content of dairy products 
and measurement of dietary intake; using a questionnaire and a single 24- hour recall may 
not provide a true representation of the impact of long-term consumption of dairy 
products. In addition, most of the studies did not use a comprehensive 
neuropsychological battery to test cognitive functions. Moreover, some studies did not 
adjust for cardiovascular health, lifestyle, and other dietary factors that may affect 
cognitive functions. Some studies did not account for a wide range of dairy products, 
such as dairy products that are involved in the preparation of mixed dishes. This 
inconclusive result could also be due to the study design (cross-sectional vs. 
longitudinal), or because the fat content was not only examined from dairy products food 
group only, but also from other food groups.  Also, some studies have examined different 
dairy products (milk, cheese, yogurt). These studies have also been conducted in different 
geographical regions. For instance, most of the studies that have been conducted to 
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investigate the relationship between dairy products fat and cognition are in countries such 
as Sweden, Finland, Japan, United States, Australia and Korea. These countries may have 
different percentages of fat incorporated in their individual processes of manufacturing 
dairy products, and other food groups in comparison to Canada.  
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3 Methods 
3.1 Participants 
A total of 35 older adults (9 males, 26 females) participated in this study (mean age 
70.23±6.86, range 61-86). Study participants’ were recruited on a voluntary basis from 
the London community. Individuals were recruited using a recruitment flyer, referral and 
face-to-face meetings. Recruitment flyers were posted at Western Retired Academic 
Associations (RAA), public libraries, church groups and the Western senior alumni 
lecture series. Permission was obtained to place the flyers along with sign-up sheets so 
that interested participants could leave their contact information if they wished to 
participate. Also, a phone number and email address was put on the flyers so that 
interested participants could contact the researcher if they chose not to leave their name 
and phone number/email address on the sign-up sheets. Potential participants were 
excluded if they were less than 60 years old, unable to communicate in English 
(read/write), lived in long- term care or assisted living facilities, or required assistance 
with activities of daily living. Also, they were excluded if they had visual impairment 
such as color blindness and/or auditory impairment uncorrected by aids. The study 
protocol was explained fully to participants (Appendix A) and all participants provided 
written, informed consent (Appendix B). The study employed a cross- sectional design to 
investigate the potential relationship between community dwelling older adults’ 
consumption of dairy products and cognitive performance on five cognitive tasks. Most 
testing was conducted in a quiet room at a public library. This study was approved by the 
Health Sciences Research Ethics Board (Appendix C).  
3.2 Measures 
3.2.1 Demographic Measures 
Demographic measures, including age, height, weight, gender, marital status, education, 
employment history and other factors were measured through a self-administered 
demographic questionnaire (Appendix D). These demographic factors have been used in 
past studies on cognitive function in older adults to describe the sample. In this 
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questionnaire, lifestyle factors, history of diseases and use of medication and supplements 
were also included.  
3.2.2 Cognitive Function Measures 
A battery of neuropsychological tests was administered to all participants by the 
researcher. The tests were selected based on previous literature. To assess the 
fundamental cognitive domains, five (2 computerized and 3 paper-based) 
neuropsychological assessments were conducted. These five tasks included the Montreal 
Cognitive Assessment (MoCA), the Rey Complex Figure Test and Recognition Trial 
(RCFT) (Appendix G), the Trial-Making Test (TMT), the Digit Span Test; both forward 
and backward (DST) and the Victoria Stroop Test (VST). Table 3 depicts the order, 
duration and delay for cognitive assessment and table 4 shows the cognitive tests and the 
domains they each examined whilst subsequent sections describe each of the tests 
administered.  
Table 3: Order, duration, and delay for cognitive assessments 
Task Trial Time to next part 
of task 
Duration 
(approximately) 
Rey Complex 
Figure Test  
Copy 3-minutes 2-10 minutes* 
The Stroop test   3 minutes 
Rey Complex 
Figure Test 
3 minute delayed 
recall 
27 minutes 2-10 minutes* 
The Digit Span Test   4 minutes 
The Trail Making 
Test 
  3 minutes 
The Montreal 
Cognitive 
Assessment 
  10 minutes 
Rey Complex 
Figure Test 
30 minutes delayed 
recall and 
recognition 
 5-14 minutes* 
 
  Total ~60 minutes 
Note. Time of task variable based on participant’s completion speed  
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Table 4: Neuropsychological tests used to measure cognitive domains 
 
 
 
 
Neuropsychological 
test 
Cognitive domain Outcome measures Descriptions 
Rey Complex 
Figure Test and 
Recognition Trial 
(RCFT) 
Visual Memory RCFT-3 minute 
delay (Immediate 
recall) (raw score) 
RCFT-30 minute 
delay (Delay recall) 
(raw score) 
RCFT- recognition 
trial (raw score) 
Number of 
elements 
correctly recalled 
Number of 
elements 
correctly recalled 
Number of 
elements 
correctly 
recognized 
 
Victoria Stroop 
Test (VST) 
Executive 
function/selective 
attention 
VST- Efficiency 
Score (C/D) 
(seconds).  
Speed of Stroop 
Colors/Speed of 
Stroop Dots 
Digit Span Test 
(DST) 
 
 
 
 
 
 
 
 
 
 
 
Trail-Making Test 
(TMT) 
Attention/working 
memory 
 
 
 
 
 
 
 
 
 
 
 
Visual attention/task 
switching/processing 
speed/cognitive 
flexibility 
DST- Forward (raw 
score) 
 
DST- Backward (raw 
score) 
 
DST -(Forward 
+Backward) (raw 
score) 
 
DST- (Forward –
Backward) (raw 
score) 
 
  
TMT- (minutes) 
Total Correct 
Forward Trials 
(raw score) 
Total Correct 
Backward Trials 
(raw score) 
Total correct 
trials forward and 
backward) (F+B) 
Total correct 
trials forward and 
backward (F-B) 
 
Speed of Trial 
Rey Complex 
Figure Test and 
Recognition Trial 
(RCFT) 
Visuospatial 
functioning 
RCFT-copy (raw 
score) 
Number of 
elements drawn 
correctly 
The Montreal 
Cognitive 
Assessment 
(MoCA) 
Global cognitive 
function 
MoCA (raw score)  
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3.2.2.1 The Montreal Cognitive Assessment (MoCA) 
The Montreal Cognitive Assessment (MoCA, 2014) is used as a screening measure to 
detect the general cognitive status and Mild Cognitive Impairment (MCI) clinical 
condition in the elderly population (Nasreddine et al., 2005). The items included in the 
MoCA measure were visuospatial/executive functioning, naming, memory, language, 
abstraction, delayed recall and orientation. A score was given for each correct answer, 
with a maximum possible score of 30 points. MoCA was included in the cognitive 
battery, as it has been used previously to assess the relationship between cognition and 
dietary interventions (De Jager, Oulhaj, Jacoby, Refsum, & Smith 2012; Sydenham, 
Dangour, & Lim, 2012; Nasreddine et al., 2005; Markwick, Zamboni, & De Jager, 2012).   
3.2.2.2 Rey Complex Figure Test and Recognition Trial (RCFT) 
The Rey Complex Figure Test and Recognition Trial (RCFT); (Meyers & Meyers, 1995) 
is used as a measure of visuospatial functioning and visual memory. RCFT was included 
in the cognitive battery, as it has been employed previously to assess the relationship 
between cognition and dietary interventions (Ho et al., 2007; Gleason et al., 2009). 
Participants were presented with a complex figure and instructed to accurately copy it 
(RCFT copy). Three minutes following the copy, participants were asked to re-draw the 
figure from memory to produce the (RCFT 3- minute- delay) score. Thirty minutes 
following the initial copy, participants were asked to again re-draw the figure from 
memory to produce the (RCFT 30- minute- delay) score. After the 30-minute delayed 
recall, participants were presented with 24 different figure designs and asked to recognize 
which of these 24 designs were parts of the original stimulus figure (recognition trial) 
score. All three drawings were scored via standardized procedures to produce the test 
scores. Two cognitive outcome measures were used from this test: First, the RCFT 
(composite score), an outcome measure of visual memory including immediate recall, 
delayed recall, and recognition trial was computed. This score was calculated by 
converting the raw score for each of these measures to overall sample-based Z-scores 
then Z-scores were averaged for the relevant measures to compute a single composite 
score for that domain. Second, the RCFT (copy score), an outcome measure used for 
visuospatial functioning was computed. Please refer to Appendix G for a copy of the 
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stimulus figure.   
3.2.2.3 The Victoria Stroop test  
The Stroop test is a timed measure of selective attention and cognitive flexibility (Stroop, 
1935; Regards, 1981). Various versions of the Stroop test are available; in this study the 
Victorian version was used (Spreen & Strauss, 1998). The Stroop test was included in the 
cognitive battery, as it is has been employed previously to assess the relationship between 
cognition and dietary interventions (Fournier et al., 2007; Pipingas et al., 2008). There 
were three parts to the task; the first part (part D (dots)) required participants to name the 
color of dots. They were given a card with six lines of four dots of four colors (red, green, 
yellow and blue). Each color was used six times, and the four colors were arranged in a 
pseudo-random order within the array with each color appearing once in each row.  
Participants had to read across the rows as quickly as possible reading out the color of 
each dot. The time to complete the task and number of errors made was recorded. For the 
second task, (part W (neutral/non-color words) a new card with six rows each with four 
words (When, And, Hard and Over) written in four different colors was used. Common 
words were printed in color and in lower case. Again, time to complete task and number 
of errors was recorded. Participants had to read across the rows as quickly as possible 
reading out the colors. The third task, the colors task, was the most difficult of the three 
Victorian Stroop tasks, and assesses the examinees’ ability to suppress usual responses 
for a less favorable, yet correct, response. In this task, a card was presented with words 
printed in any of the four colors; however, the words were the four aforementioned colors 
(e.g., the word green printed in the color red). Participants were asked to name the colors 
of ink of the printed words, not the actual word. This task required the participant to 
inhibit the automatic response of reading the word, for the more difficult task of naming 
the color. Time to complete the task and number of errors were recorded. Before the 
actual test began, the individual had the opportunity to learn what they were required to 
do on each part of the test. The first and second part of the test was used to measure 
cognitive speed, whereas the third part of the test was used to measure response 
inhibition (Verhaeghen & Cerella, 2002). Paper-based administration of the test required 
that, if an error was made, the participant had to correct the error before continuing to the 
next item and this was reflected in the completion time of the test. The approximate time 
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to administer this test was five minutes. The Victoria Stroop Test (VST) efficiency score 
was calculated by dividing C (colored words part) by D (dots part). 
3.2.2.4 PEBL- Digit Span (DS) test 
Digit span is a measure of attention and concentration, and is incorporated in the 
Wechsler Memory Scale (WMS) and the Wechsler Adult Intelligence Scale (WAIS-III); 
(Wechsler, 1997). The digit span test was included in the cognitive battery, as it has been 
employed previously to assess the relationship between cognition and dietary 
interventions (Eussen et al., 2006; Dangour et al., 2010; Fournier et al., 2007). The digit 
span task comprises two separate trials: digits forward and digits backward. Before the 
actual test administration, the participant was given a practice trial. Then, the actual test 
was administered using a laptop computer running the Psychological Experimental 
Building Language software program (Mueller & Piper, 2014). First, in the digits 
forwards task, a random number sequence consisting of three numbers was presented 
visually on the computer to the participant. After the numbers disappeared, the participant 
was required to type in the digits in the space provided on the computer by using the 
keyboard. This was followed by another sequence of the same length. Following correct 
performance on the pervious shorter sequences, sequences with one extra number were 
generated by the computer and the process continued until the participant made an error 
on both of the two sequences of the same length. In the digits backwards task, the process 
was the same as digits forwards except that the participant had to type in the numbers 
backwards. Both tests continued to a maximum of 10 numbers unless the participant 
failed earlier. Digit Span Forward scores reflected the highest number of correctly 
repeated consecutive digits (DST- F). Digit Span Backward scores reflected the highest 
number of correctly repeated consecutive digits in the backward order (DST-B). The sum 
of correct digits forward and digits backward made up the total digit span score (F+B), 
whereas the difference of correct digits forward and digits backward made up the total 
digit span score (F-B).  
 
3.2.2.5 PEBL-Trail-Making test 
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The Trail Making Test (TMT) has been incorporated into prominent neuropsychological 
batteries such as the Army Individual Test and Halstead-Reitan Neurological Battery as 
an assessment of visual search, psychomotor speed and cognitive flexibility (Reitan & 
Wolfson, 1985; Crowe, 1998; Tombaugh, 2004). Visual search is a measure of indvidual 
ability to scan an environment for a specific target amongst distractions (Eckstein, 2011), 
while cognitive flexibility is defined as the individual’s ability to shift and adapt 
cognitive processing and speed in response to different circumstances (Eslinger & 
Gratton, 1993). TMT was included in the cognitive battery, as it has been employed 
previously to assess the relationship between cognition and dietary interventions 
(Gleason et al., 2009; Crews et al., 2005; Karr et al., 2012). TMT is a timed measure of 
processing speed, executive function, visual attention, cognitive flexibility and task 
switching. Before the test began, the participants were given a paper-based practice 
session to ensure understanding and familiarity with the test. Then, the actual test was 
administered using the Psychological Experimental Building Language (PEBL version 
0.14). There were three parts to the task; the first part (TMT- Numbers) of the test 
required the participant to click on each circle of the 26 circles numbered from 1-26 in 
numeric order as quickly and accurately as possible. The circles were arranged in a 
random order on the screen. The time to complete each of these trials was recorded and if 
errors were made, they were corrected and this was reflected in the completion time of 
the trial. This part of the test is considered an assessment of visuomotor speed. For the 
second task (TMT- Letters), the participants were presented with 26 circles with letters 
A-M arranged in a random order on the screen and required the participant to click on 
each circle in alphabetical order as quickly and accurately as possible. Also, if errors 
were made, they were reflected in the completion time of the trial. This part of the test is 
also used to assess the visuomotor speed.  The third task, the numbers and letters task, is 
the most difficult of the three parts of the Trial-Making test, and assesses the ability to 
switch between numbers and letters as quickly and accurately as possible. In this task, 
participants were presented with 26 circles arranged in random order on the screen. These 
26 circles alternated between numbers (1-13) and letters (A-L), and participants had to 
click on them in alternating order (1-A-2-B-3-C and so on). This part of the test was used 
to evaluate cognitive flexibility in addition to visual scanning (Crowe, 1998). The time to 
complete each of these trials was recorded and error correction was reflected in the 
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completion time of the task. Participants were instructed to use the computer mouse and 
click circles in sequential numeric (1-2-3-4---), alphabetic (A-B-C-D-----) or 
alphanumeric (1-A-2-B-3-C----) order.  When the correct sequential circle was clicked, a 
computer-generated line (trail) connected the circles together. The process continued until 
all 26 circles were joined together. Timing did not begin until the first circle was clicked, 
which is labeled “1” on every trial.  There were six trials in total; with each part having 
two trials, alternating between numbers, letters and numbers and letters. The average of 
these six trials made up the total time in seconds required to complete the Trail-Making 
test. The approximate time to administer this test was 5-10 minutes.  
 3.2.3 Physical activity measures 
3.2.3.1 The Yale Physical Activity Survey (YPAS) 
The Yale Physical Activity Survey (Dipietro et al., 1993) was used to assess the 
participants’ physical activity level. YPAS was included in the battery because it is 
sensitive enough to detect the lower ranges of physical activities engaged in by older 
adults (Dipietro et al., 1993). The YPAS contains a wide range of physical activities 
including those involved in household chores, recreation, and structural exercises. It is a 
measure of physical activity level in adults over 60 years of age. Participants were 
required to report the frequency and duration of physical activity in five categories 
(vigorous, leisurely walking, moving standing and sitting) during a typical 7-day period 
and over the previous month. An index score for each of these categories was computed 
as a product of frequency, duration, and a weighting factor for each of the physical 
activities in a category. A summary score, known as the Yale index, was computed as the 
sum of the index scores across the above- mentioned five categories.  
 
 
 
3.2.4 Dietary measures 
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3.2.4.1 Food Intake Record (FIR)/Diary  
Dietary intake, with a particular focus on dairy product intake (whether consumed 
directly or incorporated into mixed dishes) was collected using a five-day food intake 
record/diary including a 2-weekend days and 3- weekdays prior to the cognitive testing to 
capture habitual or “usual” dietary intake. This food intake record/diary was used to 
collect information about the time of meal intake, the amount and type of all food and 
beverages, and how it was prepared (i.e., raw, fried, boiled), as well as all main 
ingredients included in mixed dishes. In addition, any medications and/or supplements 
eaten or drank by the participants were recorded on the diary for each day. The food diary 
required the participants to write down everything they consumed from the time they 
woke up until the time they went to sleep. Participants were given a folder, which 
included pamphlets that contained sets of photographs of types and portion sizes of foods 
to help them determine the quantities ingested and a set of instructions to help them 
record their dietary intake. Also, the diary (five pages of food intake record; one page for 
each day) was included in this folder for participants to record their dietary intake. This 
diary was structured with headings relating to the time of consumption, actual food eaten, 
and preparation of food, brand name and amount eaten. A “comment” section was 
included at the end of each day for participants to write down any relevant additional 
information. A sample practice of how to fill in the diary (1-day food intake record) was 
practiced with the participants to ensure that they could record information as accurately 
as possible. This practice session was conducted during the first visit/interview between 
the participant and the researcher. In the second visit, the researcher inspected the food 
intake record for completeness and that sufficient details had been recorded. Following 
input of this diary into the computer software program, the independent variables were 
the saturated fat (g), calcium (mg), and vitamin D (mcg) over the five days. This was 
done to obtain a more reliable estimate of the “usual food consumption” .The diary was 
inputted by the researcher into a computerized nutritional data analysis software program 
(ESHA), which uses the USDA food composition table databank as the reference source 
for nutrient composition. All dairy products ingested were coded and converted into 
energy and nutrients. The tables of recommended intakes of energy and nutrients for the 
Canadian population were used to calculate the Recommended Dietary Allowances 
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(RDA) for vitamin D, calcium and other nutrients and the Acceptable Macronutrient 
Distribution Range (AMDR) for saturated fat and other nutrients for this population 
group. Comparisons between observed intakes and RDA and AMDR were used to assess 
the adequacy of the diet as well. 
3.3 Procedures 
Participants who were willing and eligible to participate in the study were scheduled for 
an initial study visit of one hour. This visit was determined upon mutual agreement of a 
suitable time and place to meet. This first-visit began with a brief overview of the study 
to ensure understanding and to review the consent form. Next, participants were trained 
on how to fill in the food diary. The participants were also given a phone number to call 
if they had any questions or concerns when filling out the diary. Instructions on how to 
fill in the Yale Physical Activity Survey were given to participants. The participants were 
then given the demographic questionnaire, food intake records/food diary and the 
physical activity questionnaire (YPAS) to be completed at home and briefly debriefed 
about the cognitive testing which would take place at the next visit. Also in this visit, a 
time and place for the second visit was arranged one week later. The participants returned 
the following week for a second and final one-hour visit. In this visit, the participants 
were given a copy of their signed informed consent and advised to keep it for their 
records. The participants submitted their completed demographic questionnaires, food 
intake records/ diaries and the Yale Physical Activity Assessment. To eliminate any 
potential distractions, cognitive testing was done in a quiet room at the public library. 
Also, cognitive testing was done individually to eliminate any potential influential 
observational behavior of one participant over the other. To standardize testing, 
participants were required to sit up straight in front of the computer screen at a distance 
of 60-65 cm. The researcher monitored participant compliance routinely. Prior to 
conducting the PEBL battery, participants were provided standardized instructions and 
reminded that both speed and accuracy of each task were important. There were five 
separate cognitive tasks: two computerized using the PEBL battery tests (TMT and DST) 
and three paper-based formats (MoCA, RCFT and VST). The PEBL (Michigan Tech 
University, Houghton, MI), a widely available Windows computer software program, 
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provided the platform for the cognitive battery. Previous research conducted by Piper and 
colleagues (2014) concluded that PEBL demonstrated similar accuracy as other 
previously validated cognitive tests when evaluating executive function. These five 
cognitive tasks were administered individually and in the same order for each participant.  
For the computer format, the tasks were administered using a personal computer running 
the Microsoft Windows operating system. The tasks were displayed on a 20-inch monitor 
and the “Fullscreen” option box was checked on the PEBL Launcher. The instructions 
were displayed on the screen and read by the experimenter to each participant and each 
participant was asked to complete each task as fast and as accurately as possible. For the 
paper format, the tasks were administered on paper and instructions were read to 
participants before the actual test.  Following the completion of each task participants 
were asked if they would like a short break and were also given the opportunity to ask 
questions. Practice sessions for the cognitive tasks (VST, TMT and DST) were 
administered to each participant before the actual test. Please see table 3 for details of the 
testing. On completing the protocol, the participants were thanked for their participation 
and asked if they would like to receive a final research report of the study findings.  
Participants were reminded that their data would remain confidential. 
3.4 Data Analysis 
3.4.1 Nutritional  
Dietary intakes were analyzed using the Elizabeth Stewart Hands and Associates 
nutritional analysis software ESHA (version 2014). Total dietary intake and dairy product 
intake only were obtained from the participant food diary and analyzed using this 
software. The USDA food composition databank was selected as the reference source for 
nutrient composition. Following the input of participant total dietary intake as well as 
dairy product intake only, a mean daily nutrient intake of vitamin D (mcg), calcium (mg), 
saturated fat (g) and other nutrients were acquired. Three servings of dairy products per 
day was assumed as the cut-off criterion diet score for dairy products as recommended by 
Canada’s Food Guide (CFG) for adults aged 51 years and over. The researcher, in 
accordance with Canada’s Food Guide, calculated the number of servings of dairy 
product intake from participants’ food diary. Dairy products were determined as the 
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consumption of any of the following food items: cheese, yogurt, dairy deserts, cream, ice-
cream, and milk. Thus, a serving of dairy product intake was calculated as follows: 1 
serving of milk (reconstituted or powdered) =250 ml (1 cup) 
1 serving of milk (evaporated)= 125ml (.5 cup) 
1 serving of fortified soy beverage= 250 ml (1cup) 
1 serving of yogurt= 175 g (.75 cup) 
1 serving of Kefir= 175 g (.75 cup) 
1 serving of cheese= 50 g (1.5 oz) 
1 serving of yogurt drinks=200 ml  
Nutrient content and scores from the cognitive battery of tests were used to complete 
statistical analyses used to answer the research hypotheses.  
3.4.2 Statistical 
Data were analyzed using the Statistical Package for the Social Sciences (SPSS) version 
17.0 for Windows. Independent (unpaired) t tests were used to investigate group 
differences in the number of servings of dairy products (<3) group and (>=3) group and 
neuropsychological tests. The independent variable was the number of servings of dairy 
products (<3) group (>=3) group and the dependent variables were MoCA, RCFT 
composite and copy scores, VST Efficiency score, TMT score and DST scores. 
Exploratory analyses were conducted using the Pearson’s product- moment correlation 
coefficient to investigate if cognitive performance on the neuropsychological tests was 
associated with the nutrients intake from dairy products only and/or from the total diet. 
Independent variables were saturated fat (g), vitamin D (mcg) and calcium (mg) and the 
dependent variables were MoCA, RCFT composite and copy scores, VST Efficiency 
score, TMT score and DST score. Linear Regression was also conducted to determine 
whether performance on cognitive tests could be predicted by the individuals’ nutrient 
intake. Independent variables were saturated fat (g), vitamin D (mcg) and calcium (mg) 
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and the dependent variables were MoCA, RCFT composite and copy scores, VST 
Efficiency score, TMT score and DST score. Each regression analyses included age and 
total energy intake as confounding variables. Significance was set at p ≤ 0.05. Caution 
should be taken when interpreting the results reported below. Since a large number of 
analyses were performed, there is an elevated experiment wide probability of type I 
errors. However, because of the exploratory nature of this study, the traditional p≤0.05 
significance level was retained. Preliminary analyses were performed to ensure no 
violation of the assumptions of normality. The interpretation of the association’s strength 
between the nutrient and cognitive test was determined according to Cohen’s (1988) 
guidelines. These guidelines are as follows: r=. 10 to .29 or r=-.10 to -.29 is small; r=. 30 
to .49 or r=-.30 to -.49 is medium; r=. 50 to1.0 or r=-.50 to -1.0 is large.  
 
 
 
 
 
 
 
 
 
4 Results 
4.1 Sample Characteristics 
Of the original 35 study participants, three were unable to complete the entire study 
protocol. Two participants had unforeseen family obligations and one participant had a 
fear of being diagnosed with dementia. The three participants were excluded from data 
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analysis resulting in a final sample of 32 participants. The sample consisted of 8-males 
and 24-females with an average age of 70.59 years (SD=7.07, range 61-86). All 
participants were community dwelling older adults residing in London, Ontario. The 
demographic and medical characteristics of the sample are presented in table 5.  
Table 5: Demographic and Health Characteristic of Older Adults  
Characteristics  N (%) 
Age Group 
   60-65 
   65-74 
   75+ 
32 
4 (12.5%) 
19 (59.3%) 
9 (28.13%) 
Gender 
   Male 
   Female 
 
8 (25%) 
24 (75%) 
Marital Status 
   Single 
   Widowed 
   Separated 
   Divorced 
   Common-law 
   Married 
 
3 (9.4%) 
3 (9.4%) 
0 (0%) 
3 (9.4%) 
3 (9.4%) 
20 (62.5%) 
Education 
   Elementary 
   High School 
   Vocational/Technical School 
College 
   University: Bachelor Degree 
   University: Post-Graduate Degree 
   Professional Degree 
 
0 (0%) 
4 (12.5%) 
2 (6.25%) 
4 (12.5%) 
10 (31.25%) 
10 (31.25%) 
2 (6.25%) 
Most Frequent Self-Reported Health 
Problems 
   High Blood Pressure (Hypertension) 
   High Blood Sugar (Diabetes) 
   High Blood Cholesterol (Dyslipidemia) 
   Obesity (High Waist Circumference) 
   Depression 
   Anxiety 
   Stress 
 
 
14 (43.75%) 
3 (9.4%) 
8 (25%) 
2 (6.25%) 
4 (12.5%) 
2 (6.25%) 
3 (9.4%) 
 
Taking Prescription Medications 
   Yes 
   No 
 
20 (62.5%) 
10 (31.25%) 
Taking Dietary Supplements 
   Yes 
   No 
 
27 (84.4%) 
5 (15.63%) 
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Consume Soft Drinks 
   Yes 
   No 
 
12 (37.5%) 
20 (62.5%) 
Consume Alcohol 
   Yes 
   No 
 
26 (81.25%) 
6 (18.75%) 
Smoking 
   Yes 
   No 
 
1 (3.13%) 
31 (96.88%) 
Physical Activity 
   Part I (Energy Expenditure Summary 
Index) 
   Part II (Yale Physical Activity Index) 
 
4023.1Kcal/week 
 
60.16 
4.2 Cognitive Performance on Neuropsychological Battery 
All participants had normal global cognitive function as evidenced by having a score of 
26 out of 30 on the Montreal Cognitive Assessment (MoCA), which corresponds to the 
criterion cut-off score used to classify individuals’ cognitive function as either normal or 
impaired cognitive function. The sample had normal scores on digit span forward and 
digit span backward as healthcare professionals usually use 6+-1 as a normal range for 
Digit Span Forward and 5+-1 for Digit Span (Hodges, 2005). The sample also had within 
the average scores for copy (33.42-29.63), immediate recall (17.65-9.00), delayed recall 
(17.29-8.60) and recognition total correct (20.23-19.33) for adults aged 60-89 years old 
for the RCFT (Meyers & Meyers, 1995). The sample had above the range score  of  
(95.9-204) seconds reported by (Tombaugh, 2004). This is due to the fact that the test 
was measured using the computer timer. However, when the timer was manually started, 
the average test score of 202 seconds was obtained, which is within the range scores 
associated with this age group. As for the Victoria Stroop test, the sample performed 
better than the average efficiency scores of (2.55-2.95) for adults aged 60-80 years and 
over reported by (Bullock, Brulot & Strauss, 1996, Spreen & Strauss, 1998). For the Dots 
part of the test (12.56-19.31) seconds, Words part of the test (16.16-23.91) seconds and 
Colors part of the test (31.32-56.98) seconds for adults aged 60-80 years and over 
reported by (Regards, 1981). Please refer for table 6 for test results.  
Table 6: Neuropsychological Outcomes for Older Adults  
Cognitive domain Neuropsychological test Mean (+-SD) 
Visual memory RCFT-3 minute delay 13.27 (6.87) 
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Note. In cognitive tests used, the higher result means better performance, except for 
Victoria Stroop Test and the Trail Making Test where the best performance is the least 
amount of time used.  
4.3 Dietary Patterns 
Only 10 participants (31.25%) reported consumption of the recommended amount of 
dairy products per day (3 servings) with one of these ten participants reporting having 
(Immediate recall) (raw 
score) 
 
RCFT-30 minute delay 
(Delay recall) (raw score) 
 
RCFT- recognition trial 
(raw score) 
 
RCFT- Composite score 
(Immediate recall+ Delayed 
recall+ Recognition) 
 
 
12.86 (6.86) 
 
19.38 (1.99) 
 
-0.069 (0.85) 
Executive function/selective 
attention 
Stroop Test Efficiency 
Score (C/D) (seconds) 
Stroop Dots (seconds) 
Stroop Words (seconds) 
Stroop Colors (seconds) 
1.56 (0.37) 
 
.1925 (.043) 
.208 (.058) 
.293 (.700) 
 
Attention/working 
memory/processing 
speed/visual 
attention/cognitive 
flexibility 
Digit Span Test Forward 
(raw score) 
Digit Span Test Backward 
(raw score) 
Digit Span Test (Forward+ 
Backward) (raw score) 
 
Digit Span Test (Forward-
Backward) (raw score) 
 
Trail Making Test (TMT) 
(seconds) 
6.25 (1.50) 
 
4.84 (1.27) 
 
11.09 (2.44) 
 
 
1.41 (1.34) 
 
 
250.59 (87.09) 
Visuospatial functioning RCFT-copy (raw score) 32.11 (4.82) 
Global cognitive 
functioning  
MoCA (raw score) 26.1 (2.32) 
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four servings of dairy products per day. The remaining 22 participants (68.75%) reported 
having either one or two servings per day. Also, 84.4% of the participants were regular 
users of dietary supplements. Most common supplements taken were vitamin D, 
multivitamin, calcium and vitamin B12. Almost half of the participants (53.13%) had 
vitamin D supplements, 43.75% reported having multivitamin, 18.75% reported having 
calcium and 9.3% reported having vitamin B12.  The most common reasons of taking 
these supplements were just an extra to the dietary intake or due to deficiency. On 
average, participants had 2079.74 kcal per day, which is considered high, as the energy 
needs of older adults should be lower than those of younger adults (Thompson, Manore & 
Sheeshka, 2007). Also, participants’ intake of saturated fat was 13 % of total calories 
intake, which is well over the recommendations of (<7% of total calories from saturated 
fat). Most participants (56.25%) had their cholesterol level within the recommendations 
of <300mg per day. However, participants’ level of vitamin D and calcium were well 
below the DRI at 100% and 84.4%, respectively. However, it is important to note that the 
current study did not take into account the supplements taken. Please refer to table 7 for 
an average intake of key nutrients from participants’ total dietary intake. 
Table 7: Average Dietary Intake of Key Nutrients from Total Diet Over Five Days 
Nutrients Mean  (SD) 
Energy (kcal) 2079.74 (616.80) 
Saturated fat  (g) 29.23 (11.09) 
Cholesterol (mg) 275.71 (121.69) 
Vitamin D (mcg) 2.32 (1.79) 
Calcium (mg) 813.02 (293.74) 
 
As for physical activity, all participants were considered physically active. Part I of the 
YPAS assesses the amount of physical activity/exercise during a typical week in five 
categories: work, yard work, care taking, exercise and recreation. Participants spent an 
average of 3.73 (2.23) hours per day doing exercise/physical activity during a typical 
week. Part II of the YPAS assesses the individual’s physical activity level over the 
pervious month. It included specific activities such as (vigorous, leisurely walking, 
moving, standing and sitting). Participants scored on average 60.16 (Yale Physical 
Activity Index) 
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4.3.1   Hypothesis (H1): Number of Servings of Dairy Products and Cognitive 
Performance 
 
Independent t tests were used to investigate group (< 3 servings versus >=3 servings of 
dairy products) differences in cognitive test scores.  Results showed that there were no 
significant differences in any of the performed cognitive tests. Therefore, visual memory 
as measured by the RCFT-composite score; visuospatial functioning as measured by the 
RCFT-copy score; executive functioning and selective attention as measured by the VST; 
working memory as measured by the DST; visual attention, processing speed and 
cognitive flexibility as measured by the TMT and the global cognitive functioning as 
measured by the MoCA were none significantly different for participants who consumed 
less than 3 servings of dairy products per day compared with participants who consumed 
3 or more servings of dairy products per day. Thus, hypothesis (H1) was not supported. 
Please refer to table 8 for neuropsychological tests scores between both groups.  
 
 
 
 
 
 
 
Table 8: Comparison of mean scores on neuropsychological tests between (< 3) and 
(>=3) servings of dairy products 
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Cognitive test outcome 
measures 
(<3 servings of dairy 
products) group 
N=22 
(>=3 servings of 
dairy products) 
group N=10 
T-test (p-value) 
RCFT-Copy Score  32.614 (3.65) 31.00 (6.85) .874 (.389) 
RCFT Composite 
Score  
.00 (1.02) -.143(.77) .394 (.696) 
Trial-Making Test 
(TMT) 
4.04 (1.23) 4.54 (1.95) -.876 (.388) 
Digit Span Test  
Forward (F) 
Backward (B) 
Forward +Backward 
(F+B) 
Forward –Backward 
(F-B) 
 
6.00 (1.38) 
4.59 (1.01) 
10.59 (1.89) 
 
1.41 (1.50) 
 
6.80 (1.69) 
5.40 (1.65) 
12.20 (3.19) 
 
1.40 (.966) 
 
-1.419 (.166) 
-1.719 (.096) 
.036 (.164) 
 
.017 (.986) 
MoCA  26.14 (1.98) 26.00 (3.06) .152 (.880) 
Victoria Stroop Test 
(Efficiency Score) 
1.59 (.43) 1.50 (.22) .791 (.435) 
Note. RCFT=Rey Complex Figure Test and Recognition Trail, TMT=Trail Making Test, 
MoCA=The Montreal Cognitive Assessment, VST=Victoria Stroop Test.  
 
4.3.2 Hypothesis (H2): Relationship between dairy product nutrient intake and 
cognitive performance 
Bivariate, Pearson-Product Moment correlations were computed between cognitive 
measures and saturated fat, vitamin D and calcium levels found exclusively in the dairy 
products consumed. Please refer to Appendix E for all of the dairy product correlational 
results. Specifically, performance on the Rey Complex Figure Test and Recognition Trial 
(as measured by the composite score) was negatively correlated with saturated fat [r=-
0.361, n=32,p=0.042]. A high level of this nutrient was associated with fewer items 
recalled and recognized by participants from the RCFT stimulus figure. There was a 
positive correlation between the level of vitamin D intake and performance on three 
cognitive tests [r=0.367, n=30,p=0.046] for RCFT; [r=0.390,n=30, p=0.033] for DSTB 
and [r=0.362, n=30, p=0.049] for MoCA. However, no correlation was found between 
the level of calcium intake in dairy products and any of the performed cognitive tests.   
To control for the potential confounding effects of age and total calorie intake, linear 
regression analyses were also employed to predict which of the following nutrients 
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(saturated fat, vitamin D and calcium) best-predicted performance on the cognitive tests. 
Analyses revealed that none of these nutrients were significant predictors on any of the 
performed cognitive tests. This means that neither of these nutrients derived from dairy 
products only have an impact on any of the cognitive domains measured by these 
cognitive tests.  
4.3.3 Hypothesis (H3): Relationship between total dietary nutrient intake and 
cognitive performance 
Bivariate Pearson–Product Moment correlations were computed between nutirents from 
participants’ total dietary intake and their performance on cognitive tests. Please refer to 
Appendix F for all of the total dietary nutrients correlation results. There was a positive 
correlation between vitamin D level and RCFT composite score [r=0.358, n=32, 
p=0.044] and MoCA [r=0.372, n=32, p=0.036], with a higher level of vitamin D 
associated with better scores on RCFT and MoCA. Another important finding was that a 
higher level of calcium was associated negatively with the Victoria Stroop test (VST). 
This indicated that a higher level of calcium was associated negatively with performance 
on the VST [r=-0.457, n=32, p=0.009]. Higher calcium levels enhanced executive 
function and selective attention as better performance on this test is associated with less 
time taken to complete the task. No other meaningful associations were found between 
any of the other nutrients in total diet and any of the cognitive tests outcome measures.  
Linear regression analyses were also employed to determine whether saturated fat, 
vitamin D or calcium levels predicted performance on the cognitive tests, taking into 
account both age and total calories from the total diet as confounding variables. Analyses 
revealed that both calcium and vitamin D levels were significant predictors for the digit 
span test (DST); both forward and backward as evidenced by having adjusted 
R^2=19.9%, F=2.545, p= .053. Also, analyses revealed that saturated fat was a significant 
predictor for MoCA performance as evidenced by having adjusted R^2=32.5%, F=3.978, 
p=.008.  In addition, calcium level was found to be a significant predictor for 
performance on Victoria Stroop test performance as evidenced by having adjusted 
R^2=22.5%, F=2.801, p=.037.  
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The justification for inclusion of the variables entered into the linear regression analyses 
for both dairy and total dietary intake was empirically based on attainment of significant 
correlations between the dependent measures of interest and each of the predictor 
variables. Thus, TMT, RCFT; both copy and composite scores, VST, DST; both forward 
and backward and MoCA were regressed for calcium, vitamin D and saturated fat, taking 
into account age, total calories from total dietary intake as cofounding variables.  Also the 
chosen nutrients were based on the fact that vitamin D, calcium and saturated are 
considered the most abundant nutrients found in dairy products. Justification for choosing 
age as a confounding variable was because age typically has an effect on cognitive test 
performance (Meyers & Meyers, 1995; Tombaugh, 2004; Regards, 1981; Gregoire & 
Van der Linden, 1997). It is also important to control for total calories because according 
to Willett, most nutrients are associated with total energy intake either because they 
contribute directly to energy intake or because individuals who consume more total 
energy also eat, on average, more of all specific nutrients and, as a result, it is important 
to control for the confounding variable total calorie intake (Willett, Howe & Kushi, 
1997).  
4.4 Adequacy of Individuals Total Dietary Intake 
Dietary data showed that 100% of the participants met the Acceptable Macronutrient 
Distribution Range (AMDR) recommendation for protein, 60% of participants met the 
AMDR for fat and 54% of the participants met AMDR for carbohydrates. In addition, the 
dietary data indicated that 100% of the participants were over the recommended intake of 
saturated fat (<7%), whereas 100% were within the recommended amount of dietary 
intake for poly fat (<10%). For cholesterol, 56.25% of the participants reported having 
their cholesterol level within the recommended amount, which is <300mg. As for the 
micronutrient level of vitamin D and calcium, participants in general were well below the 
recommended amount of dietary intake according to the dietary reference intake 
guidelines for vitamins and minerals with 100% and 84.4% for vitamin D and calcium, 
respectively. Table 9 presents the adequacy of dietary intake of macronutrients 
(carbohydrates, fat and protein), Polyunsaturated fatty acids and major vitamins and 
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minerals. In general, the micronutrients of vitamin and minerals levels were below the 
Dietary Reference Allowances (RDA).  
 Table 9: Adequacy of dietary intake  
Nutrients Recommendations Within Below  Over 
Carbohydrates 45-65% 53.1% 46.9%  
Protein 10-35% 100%   
Fat 20-35% 59.4%  40.6% 
Saturated Fat <7%   100% 
Monounsaturated 
Fat 
10-15% 3.1% 96.9%  
Polyunsaturated 
Fat 
<10% 100%   
Cholesterol <300mg  53.1% 46.9% 
Poly Fatty Acids     
Omega-3 Fatty 
Acids 
M= 1.6g/day 
F=1.1g/day 
3.1% 62.5% 34.4% 
Omega-6 Fatty 
Acids 
M=14g/day 
F=11g/day 
 90.6% 9.4% 
Ratio 6/3 2:1   6.25% 93.8% 
Vitamins     
Vitamin B12 2.4 mcg/day  53.1% 46.9% 
Vitamin D 51-70 years 
15mcg/day 
 
>70 years 
20mcg/day 
 100%  
Vitamin A M=900mcg/day 
F=700mcg/day 
 71.9% 28.1% 
Folate 400 mcg/day  87.5% 12.5% 
Vitamin B2 
(Riboflavin) 
M=1.3 mg/day 
F=1.1mg/day 
3.1% 37.5% 59.4% 
Minerals     
Calcium M=51-70 years 
1000mg/day 
F=51-70 years 
1200mg/day 
 
>70 years (M and 
W) 
1200mg/day 
 84.4% 15.6% 
Sodium 51-70 years (M and 
F)= 1300mg/day 
>70 years= 
1200mg/day 
 3.1% 96.9% 
Iron 8mg/day  15.6% 84.4% 
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Magnesium M=420mg/day 
F=320mg/day 
 96.9% 3.1% 
Phosphorus 700mg/day  56.3% 43.8% 
Potassium 4700mg/day  96.9% 3.1% 
Zinc M=11mg/day 
F=8mg/day 
 93.8% 6.25% 
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5 Discussion 
The purpose of this study was twofold: first, to examine whether there is a difference in 
cognitive performance between individuals who consume the recommended amount of 
dairy products (3 servings per day) and individuals who consume less than the 
recommended amount (<3 servings per day); second, to investigate whether there were 
associations between levels of dietary nutrients and performance on a battery of cognitive 
tests. The final sample consisted of older adults (8 males, and 24 females) with a mean 
age of 70.59 ±7.07 years. Most had at least a high school diploma. The mean participants’ 
body mass index (BMI) was 27.59kg/m^2, which, according to the World Health 
Organization (2000), is considered a normal healthy body mass index for an older adult 
aged 60 years and over (WHO, 2000; Health Canada, 2003).  Most of the participants had 
some form of metabolic syndrome, which is defined as a clustering of cardiometabolic 
risk factors such as abdominal obesity (high waist circumference for males >=102 cm 
(40inch) and for females >=88cm (35inch)) (National Institute of Health, 1998), 
dyslipidemia (high blood cholesterol), hypertension (high blood pressure) and diabetes 
(high blood glucose). Some participants had either one or a combination of these medical 
conditions.  About half (14) of the participants reported having hypertension, 3 reported 
having diabetes, 8 reported having dyslipidemia and 2 reported having high waist 
circumference. These cardiometabolic risk factors may contribute to a 1.7 fold increase in 
the risk of developing cardiovascular diseases (CVD), which are considered risk factors 
for cognitive decline (Crichton, Bryan, Buckley, &Murphy, 2010). According to Whitmer 
et al. (2005), the risk of dementia increases from 1.27 for having one risk factor to 2.37 
for having all four cardiovascular risk factors (Whitmer et al., 2005). Many (22) of the 
participants (68.7%) were found to consume less than the recommended amount of dairy 
products (3 servings per day) according to Canada’s Food Guide (CFG) for adults aged 
51 + years and older. This is consistent with a 2004 Canadian national nutritional survey 
finding that the average intake of those aged 19 years or older was 1.5 serving of dairy 
products per day (Garriguet, 2007). This low consumption pattern of dairy products is 
consistent with intakes in other parts of the world. For example, according to the most 
recent Australian national nutritional survey, the average Australian adult consumes 
between 1 and 1.5 servings of dairy products per day (Australian Bureau of Statistics, 
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1998) while in the United Kingdom, milk consumption has fallen by 33% over the past 
25 years (Elwood, 2005). The potential implications of the present research study are now 
discussed.  
5.1 Effect of Number of Servings of Dairy Products on Cognitive Performance 
With respect to the first hypothesis, there were no significant differences on mean 
cognitive test scores between the group that consumed less than 3 servings of dairy 
products per day versus the group that consumed 3 or more servings per day.  This 
finding of the present research study is incongruent with the study conducted by Crichton 
who reported that participants who consumed at least one dairy product serving per day 
had significantly higher scores on multiple domains of cognitive function compared with 
those who never or rarely consumed dairy products (Crichton, Elias, Dore & Robbins, 
2012).  In another study, Crichton reported that participants who consumed 4 servings of 
dairy products per day had better performance on spatial working memory following six 
months compared to individuals who consumed 1 serving per day (Crichton, Murphy, 
Howe, Buckley & Bryan, 2012). According to Crichton and colleagues, this means that 
consuming at least one serving of dairy products per day can have an impact on cognitive 
performance when compared to non-consumers or that impact on cognitive performance 
was observed when comparing higher amounts (4 servings) to lower amounts (1serving) 
of dairy products per day.  The difference in cut-off values may be one reason for the 
difference between the present study and those of Crichton. Another reason may be the 
fact that, in the present study, there were only 10 participants who consumed the 
recommended amount of dairy products per day compared to 22 participants who did not. 
Also, the insignificant result in the present study could be due to the fact we did not 
control for any demographic, lifestyle, other dietary consumption, supplement use and 
cardiovascular factors. Such factors should potentially be considered for future research 
examining the impact that dairy products might have on cognitive function. 
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5.2 Relationship between Dairy Product/Total Dietary Intake Nutrient Levels and 
Cognitive Performance   
With respect to the second and third hypotheses, several associations were found between 
the levels of nutrients found in dairy products/ total dietary intake and older adults’ 
performance on the cognitive tests.  
5.2.1 Vitamin D and Cognitive Function 
The level of vitamin D in dairy products and in the total diet was associated with higher 
scores on the Montreal Cognitive Assessment test (MoCA). This is congruent with 
Rondanelli et al. (2007) who reported that lower dietary intake of vitamin D from total 
diet was associated with lower scores on the MoCA (Rondanelli et al., 2007). In addition, 
the present study is the first to find an association between vitamin D level in dairy 
products only and performance on MoCA. This suggests that further research is needed to 
support the present study finding. Also, the present study showed that the level of vitamin 
D was associated with performance on the digit span backward test. This is congruent 
with Andreeva (2014) who reported that midlife vitamin D intake was positively 
associated with scores on the forward digit span test (Andreeva et al. 2014). Although the 
present study results found an association with the backward version as opposed to the 
forward version, this shows a promising result of the possible beneficial impact that dairy 
products’ level of vitamin D might have on working memory; specifically, the storage 
and executive processing components of the working memory. However, after controlling 
for total calories and age, that both vitamin D and calcium from total diet (in 
combination) were significant predictors on both Forward and Backward digit span test. 
The present study found a positive association between the level of vitamin D contained 
in dairy and the number of correctly recalled elements immediately (for the immediate 
recall), after 30 minutes (for the delay recall) and also correctly recognized elements (for 
the recognition trial) on the Rey Complex Figure Test and Recognition Trial (RCFT). 
The study also found an association between total dietary intake of vitamin D and RCFT 
performance. This is considered the first study to examine the level of vitamin D 
contained in dairy products only and/or from total diet and performance on RCFT 
performance, which suggests that vitamin D might have an impact on visual memory as 
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well. In summary, the present study indicates that the level of vitamin D contained in the 
diet of older adults might have a positive effect on global cognitive function as measured 
by MoCA, working memory as measured by digit span backward test and visual memory 
as measured by RCFT.  
Currently, little is known about the exact mechanisms by which vitamin D can affect 
cognitive performance. However, vitamin D is a fat-soluble vitamin and as a result, can 
cross the blood brain barrier and can bind to vitamin D receptors located in the human 
cortex and hippocampus, key areas for cognition (Kalueff & Tuohimaa, 2007). These 
receptors, along with the enzyme 1 alpha hydroxylase are responsible for transforming 
the inactive form of vitamin D to the active form in the brain region, which are 
widespread in both neuron and glial cells within the brain (Kalueff & Tuohimaa, 2007). 
The neuro-protective effect of vitamin D is associated with a reduction in calcium ions in 
the brain as a high level of calcium is associated with neurotoxicity and consequently 
neuronal death (Shinpo et al., 2000; Kalueff, Eremn, & Tuohimaa, 2004). This could 
occur via two mechanisms: first, vitamin D could stimulate the expression of calcium 
binding proteins or inhibit the expression of calcium channels in the hippocampus (Losel 
& Wehling, 2003). Both mechanisms protect neurons against toxic damage by reducing 
calcium levels in the neuron cell (Losel & Wehling, 2003). The second mechanism by 
which vitamin D might impart its effects on the nervous system is through its role in 
autoimmune processes. Vitamin D acts as an inducer of anti-inflammatory neurotrophin 
proteins such as nerve growth factors and decreases the pro-inflammatory proteins such 
as tumor necrosis factor (Garcion et al., 2002; Garcion et al., 2003). For example, the 
induction of the neurotrophin such as nerve growth factor decreases the degenerative 
processes in hippocampus in rats during aging and the progression of Alzheimer disease 
(Brown, Dusso & Slatopolsky, 1999; Langub, Herman, Maluche & Koszewski, 2001). 
This suggests the importance of the anti-neurodegenerative activity of vitamin D and that 
it might be the mechanism by which vitamin D has an effect on cognitive function 
(Kalueff & Tuohimaa, 2007).    
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5.2.2 Calcium and Cognitive Function 
No bivariate correlations were found between the level of calcium in dairy products and 
performance on any of the cognitive tests. This is surprising as calcium is considered the 
most abundant nutrient in dairy products with 53% of calcium in Canadian’s diets 
contributed by the consumption of dairy products (Agriculture and Agri-Food Canada, 
2009). However, after controlling for age and total caloric intake the regression analyses 
showed an association between the total dietary intake of calcium and performance on the 
Victoria Stroop Test (VST), with a higher calcium intake was associated with better 
performance. This indicates that calcium levels might have an effect on executive 
functioning and selective attention as measured by VST efficiency score. In addition and 
after controlling for total calories and age, that both vitamin D and calcium from total diet 
(in combination) were significant predictors on both Forward and Backward digit span 
test.  These finding is supported by numerous studies used to investigate whether there 
was an association between dietary calcium and performance on cognitive tests. Velho et 
al. (2008) found that a diet high in calcium was associated with improved cognitive 
function as measured by the Mini-Mental Status Examination (MMSE). Another study 
conducted by Lee et al. (2001) showed that a low intake of calcium and dairy products 
was associated with lower scores on global cognitive function as measured by the 
MMSE.  Ozawa et al. (2012) revealed that a higher self-reported dietary intake of 
potassium, calcium and magnesium was associated with a lower incidence of all-cause 
dementia, especially Alzheimer’s disease and vascular dementia. This is supported by 
another prospective, longitudinal study in Japan on 1774 non-demented subjects. Dietary 
intake was assessed via self-administered questionnaire, while cognitive function was 
assessed via Cognitive Ability Screening Instrument (CASI) and cognitive 
questionnaires. Results showed that increased blood pressure, a risk factor for 
cardiovascular and cognitive decline later in life, as well as lower milk intake in midlife, 
was associated with Vascular dementia (VaD) detected 25 to 30 years later (Yamada, 
Kasagi, Sasaki, Masunari, Mimori, & Suzuki, 2003). Consuming more than the 
recommended dietary intake of calcium does not lead to neuronal death due to toxicity 
(because this excess dietary consumption will not be absorbed from the intestine), but is 
rather excreted in the feces (Thompson, Manore, & Sheeshka, 2007). This indicates that 
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low cognitive performance could only be due to low dietary intake of calcium as opposed 
to an excess amount. This low consumption is due to many factors: first, as adults get 
older, their capacity to absorb calcium from the intestine decreases. Second, unbalanced 
eating habits due to health issues, along with a higher need for calcium than can be 
obtained from balanced diet, will promote individuals to consume calcium supplements 
to fulfill their needs.   
Little is known about the exact mechanisms by which dietary calcium has an impact on 
cognitive function. However, it has been suggested that the primary mechanisms by 
which dietary calcium imparts its effects on cognitive function is indirectly via mediating 
effects on cardiometabolic health. Hypertension has been recognized as a significant risk 
factor for cardiovascular diseases, stroke and vascular dementia (VaD) (Sharp et al., 
2011).  It has been reported that dietary calcium has favorable effects against 
cardiovascular diseases through the antihypertensive properties of this mineral (Houston 
& Harper, 2008;Nakamura et al, 1995; McCarron & Reusser, 2002), improvement of 
dyslipidemia (Karanja et al., 1987) and lower rates of obesity (Astrup, Chaput, Gilbert, & 
Lorenzen, 2010). According to Resnick, a reduction in dietary calcium may result in 
calcium depletion from all membrane storage sites, resulting in less stability of the 
vascular smooth muscle cell membrane (Resnick, 1991; Resnick, 1992). However, when 
there is an optimal concentration of dietary calcium, it stabilizes vascular cell membrane, 
inhibits its own entry into cells, and reduces vasoconstriction, reducing blood pressure 
(BP) (Undurti, 2001). Calcium has been found to have a particular benefit on serum lipid 
profiles, with increased levels of calcium, increasing HDL-cholesterol while decreasing 
both total and LDL-cholesterol (Van Meijl, Vrolix & Mensink, 2008). A possible 
mechanism by which calcium may affect lipoprotein metabolism is through the inhibition 
of fat absorption in the small intestine (Denke, Fox & Schulte, 1993). In addition, dietary 
calcium has been associated with lower rates of obesity, which results in weight reduction 
through an increase in satiety due to consumption of dairy proteins (Astrup et al., 2010) 
and to the impact of calcium on fat excretion (Astrup et al., 2010). According to Astrup et 
al. (2010), increasing dairy calcium consumption by 1200mg/day resulted in increased 
fecal fat excretion by 5.2g/day as calcium forms insoluble fatty acids soaps and other 
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hydrophobic aggregations of bile acids, phosphorous, and fatty acids in the small 
intestine, resulting in greater fat excretion (Astrup et al., 2010).   
5.2.3 Saturated Fat and Cognitive Function 
The level of saturated fatty acid in dairy products was associated negatively with RCFT 
performance as measured by the composite score. A higher amount of saturated fat 
contained in dairy products was associated with fewer items remembered immediately 
(immediate recall), after 30 minutes (delayed recall) and recognized (recognition trial). 
This indicates that saturated fatty acids might have an impact on the visual memory 
domain. This finding is supported by a wealth of research (Laitinen et al. 2006; Morris et 
al., 2004; Eskelinen et al., 2008; Kalmijn et al., 2004; Vercambre et al., 2009; Ortega, et 
al., 1997; Crichton, et al., 2010; Morris et al., 2006). These research studies suggest that 
high intake of saturated fatty acids from total dietary intake was associated with poorer 
global function and worse scores on multiple cognitive domains (Eskelinen et al., 2008; 
Kalmijn et al., 2004; Vercambre et al., 2009; Ortega et al., 1997; Crichton, et al., 2010; 
Almeida, Norman, Hankey, Jamrozik, & Flicker, 2006; Gu, Nieves, Stern, Luchsinger, & 
Scarmeas, 2010). There is also a plethora of research studies that have examined the 
effect of saturated fatty acids from dairy products on cognitive function. Studies have 
shown that moderate to high levels of saturated fatty acids from dairy products and 
spreads were associated with poorer global cognitive function and prospective memory 
(Laitinen et al., 2006), and cognitive decline (Morris et al., 2004; Solfrizzi et al., 2008). 
This is supported by the present study and after controlling for age and total calories from 
total diet, saturated fat was found to be a significant predictor on MoCA; with higher 
level of saturated fat associated with poorer global cognitive function. The potential 
mechanisms by which saturated fatty acids affect cognitive functioning in the elderly 
cannot be derived from the present study. However, there are findings from other studies 
that suggest increasing level of SFS lead to increases in low-density lipoprotein, which is 
considered a risk factor for dyslipidemia, a component of metabolic syndrome and a risk 
factor of cardiovascular diseases (NIH, 2002;Huth & Park, 2012), and, therefore for 
cognitive decline, VaD and AD (Solfrizzi et al., 2005). A diet rich in SFA is deleterious 
and positively associated with cardiometabolic risk factors such as diabetes, 
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hypertension, dyslipidemia, and obesity (components of metabolic syndrome), which are 
also risk factors for cognitive decline, dementia and lower scores on tests of cognitive 
functions through white matter lesions, which are critical for cognition (Breteler, 1994). 
Further, in experimental studies on rats, a Western diet with 40% saturated fatty acids and 
1% cholesterol may increase hippocampal accumulation of amyloid beta-peptide (AB), a 
pathogenic marker of Alzheimer’s disease (Oksman et al., 2006). In addition, a diet high 
in SFA may lead to cognitive impairment through alteration of the fatty acids 
“phosphatidylcholine” profile in the brain (Greenwood & Winocur, 1996) and cerebral 
oxidative stress or neural inflammation via increased level of reactive oxygen species 
(ROS) (Zhang, Dong, Ren, Driscoll, & Culver, 2005). Also, SFA has decreased the levels 
of hippocampal brain-derived neurotrophic factor (BDNF), which is relevant for neuronal 
plasticity, and the maintenance of cognitive function (Molteni, Barnard, Ying, Roberts, & 
Gomez-Pinilla, 2002). According to that study (on rats), SFAs decreased the level of 
neurotrophins such as brain–derived neurotrophic factor (BDNF), which is important for 
neurotransmitter release, learning and memory in the hippocampus and thus low 
performance on spatial learning memory tasks. This indicates that an individual should 
practice caution when consuming saturated fat as it had a negative impact on cognitive 
function.  
5.3 Limitations 
There are several limitations associated with the present study that should be 
acknowledged. First, the independent sample t- tests did not reach statistical significance 
between the less than 3 serving and greater than 3 servings of dairy products per day on 
any mean cognitive test scores. The inability to detect a significant difference could be 
attributed to the relatively small sample size in general and specifically the number of 
people who consumed the recommended amount of dairy products. Second, the sample 
size may not be representative of the general older adults population and this would affect 
external validity (generalizability). The current sample was predominately highly 
educated with at least high school diploma and was therefore, homogenous. The majority 
were white females who did not smoke and only consumed small to moderate amounts of 
alcohol. Therefore, conclusions drawn from the current study cannot be generalized to 
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other groups. These associations need to be replicated in a larger population sample. 
Also, participants who are interested or concerned about their health may be more likely 
to participate in health research, and subsequent reporting bias may therefore exist. Third, 
residual confounding variables by unknown risk factors, such as gender, education, 
number of supplements, number of medications, body mass index (BMI), depression 
status and genetics may play an important role in altering the outcomes.  It was not 
possible to control for these because of the limited sample size. As a result, further 
research into the area should, where possible, control for as many of these variables as 
possible and will need rather a large sample to do so. Fourth, the sample included more 
women (24 out of 32 participants), which likely stems from the fact that women’s life 
expectancy is higher than men’s and the risk of dementia increases sharply with age 
(World Health Organization, National Institute of Aging & National Institute of Health, 
2011). Thus, recruiting an equal numbers of males and females could result in significant 
results on cognitive test between both genders. Fifth, the current study is a cross-sectional 
analysis and cannot address cause-and-effect relationships, namely cognitive performance 
affecting dietary intake or dietary intake affecting cognitive performance. Thus, 
longitudinal study and specifically intervention studies would be beneficial to provide a 
clearer profile of causality and underlying mechanisms of the role of specific nutrients on 
cognitive function.  
Sixth, the dietary measurement method is based on self-reported data, which could be 
problematic in older adults due to their cognitive abilities, or underestimation or 
overestimation of true associations. Furthermore, measurement at only one point in time 
may not reflect long-term consumption patterns. Thus, administering a variety of dietary 
assessment methods as well as at different time points would act as a valid method. 
Seventh, the neuropsychological test battery was not as comprehensive (measuring every 
cognitive domain) as it could have been due to time and expertise limitations.  Thus, 
including more neuropsychological tests would be beneficial to measure every aspect of 
cognitive function. Finally, no blood sample was collected and having only one measure 
(dietary intake measure) might not be of accurate representative of the nutrient status of 
an individual. Thus, biochemical assessments based on blood or tissue concentrations 
will reflect the nutrient life as some nutrients such as fatty acids have long life compared 
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to others. As a result, a combination of dietary, biochemical, clinical, and anthropometric 
methods can be regarded as the “gold standard” in estimating individual nutritional status. 
In addition, study participants had a wide age range and, as a result, the observed 
association between nutrient levels and task performance were somewhat overshadowed 
by the wide age range. Thus, selecting a narrower age range would help to omit the 
effects of particular age on task performance will help better identify the precise role of 
nutrients during the aging process. While this would make the process of recruitment 
significantly more time consuming and may reduce the sample size even more, it would 
help construct a set of age ranges by which cognitive function may be more susceptible to 
level of nutrients.  
5.4 Strengths 
Firstly, diet and cognitive function were assessed using previously validated dietary and 
neuropsychological instruments that have been widely used in both cross-sectional and 
epidemiological studies. These cognitive tests have been used in other studies 
investigating dairy products (response to the dairy products) and, as a result, they are 
sensitive and reliable to the measured cognitive domain. Second, most of the study 
participants were recruited via face-to-face and it was the most effective means of getting 
a higher number of participants. The present study is in line with Resnick et al. (2003) 
who reported that face-to-face contact was the most effective recruitment method for 
older women because it facilitated easier communication. Third, the neuropsychological 
test battery included both paper and computer-based cognitive tests. This ensures there 
was a variety to avoid any boredom or inconvenience caused by using the computers only 
and in case older adults were not familiar with computer usage. Finally, the five-day food 
intake records were able to capture participants’ food intake. This is evidenced by the fact 
that the participants did not appear to change their eating patterns by reducing the number 
of foods and snacks consumed or decreasing the complexity of their diet by substituting 
food that is simpler to record. Keeping food intake records can result in significant 
changes in eating patterns, which could affect the ability of the researcher to capture an 
accurate picture of usual dietary intake. To minimize changes in eating patterns, it is 
suggested that food intake records should avoid lengthy periods of consecutive days (e.g. 
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7-day food intake records) (Block, 1989; Feskanich et al., 1993; Rebro, Patterson, Kristal, 
& Cheney, 1998).  
5.5 Conclusion 
The results of the present study revealed that nutrient levels from dietary intake were 
uniquely associated with specific cognitive functions in older men and women. Although 
the explained variance in visual memory and processing speed and flexibility was 
modest, it is important to remember that participants in this study were already 
functioning at a high level. It is suggested that future research about the effect of dairy 
products on cognitive performance should be investigated with a wider range of 
participants. Prevention strategies are needed to impede an increased prevalence of 
cognitive dysfunction. Intervening to prevent cognitive decline and impairment can help 
prevent adverse health outcomes such as dementia. Intervention through simple steps 
such as dietary intake could have important implications for health care and the economic 
system as dementia costs the North American care system billions of dollars in direct and 
indirect costs. These results contribute to increased evidence indicating that nutrient 
intake could influence cognitive function in the older adult population.  
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Appendices  
Appendix A: Letter of Information 
Research Title: Relationship between Dairy product consumption and cognitive 
performance in a group of community-dwelling healthy older adults living in London, 
Ontario, Canada 
 
Members of the Research Team: 
Dr. Alan Salmoni (principle investigator), Health Sciences, School of Kinesiology, 
Western University, 519 661 3541 x 83541 
Mariam Ismail (Master student), Health Sciences, School of Kinesiology, Western 
University, 519 870 2102 
 
Background: 
I am a master student at Western University in the school of kinesiology conducting a 
study on the effect of dairy product consumption on cognitive performance in 
community-dwelling healthy older adults living in London, Ontario, Canada. I would like 
to invite you to participate in this research study to investigate the potential relationship 
of consuming dairy products on cognitive function. The purpose of this letter is to 
provide you with the information needed to make an informed decision about 
participating in this research study. Please read the following information carefully and 
do not hesitate to ask the research team any questions to clarify any points or phrases. If 
after reading the below information and you wish to participate in this research, please 
sign the consent form provided at the end of the package.  
 
Why should you take part in this study? Why are we doing this study? 
You are being invited to partake in this research study because you are an older adult 
living in the community. The purpose of this research study is to investigate the potential 
effect of consuming dairy products on cognitive performance in community-dwelling 
healthy older adults living in London, Ontario, Canada.  
 
Why is this study being done? 
As the proportion of adults aged 60 years and older is expected to increase rapidly in the 
near future, it has become important to better understand the cognitive changes that 
accompany normal aging. With age, many older adults experience changes in their 
thinking abilities, for instance, they face difficulties in mathematical calculations, 
attention-requiring activities, and memory retention. In response to the increasing aging 
population, and the great societal impact of age-related cognitive decline combined with 
the absence of curative treatment, there has been a tremendous amount of research on the 
development of effective dietary interventions that may help ameliorate age-related 
cognitive decline and diet is one of the modifiable factors. The association between diet 
and cognitive function has been a topic of interest over the past two decades. Dietary 
habit is a modifiable factor that can be targeted as an appropriate intervention to optimize 
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the cognitive function of an aging person. There are positive associations between 
cognitive function and a number of nutrients, including antioxidants (vitamin C, and E), 
omega 3 and omega 6 polyunsaturated fatty acids, fruits and vegetables, and vitamin B 
complex (vitamin B6 and B12, and folate). However little research has been paid to the 
potential impact dairy products have on cognitive function in comparison to other 
nutrients. As a result, it is time to investigate the potential relationship of dairy products 
have on cognitive performance. 
 
Who is eligible for this study?  
If you are 65 years of age or older, have the ability to understand and read English, 
community-dweller and live independently at home, then you are eligible to participate in 
this study. If your age is less than 65 years of age, inability to understand or read English, 
live in an assisted living or long term care facility, have significant visual or hearing 
impairment uncorrected by aids, then you will be excluded. 
 
What is being asked of you as a participant?  
 
If you agree to take part in this research study, the procedures and visits you can expect 
will include the following: you will be asked to take part in two visits that will take 
approximately 2 hours in total of your time; 1-hour for each visit at a previously arranged 
and agreed upon location and time between the researcher student and the participating 
participant.  These two visits will take part place over a 1-week period.  
 
If you are eligible and willing to participate in the study, you will be scheduled for an 
initial (first study visit1) of 1-hour. In this visit: The researcher student will review the 
informed consent form with you and answer any questions you have about the study. 
Next, a short cognition test called the Montreal Cognitive Assessment (MoCA) will be 
administered by the researcher student. Also, an educational session by the researcher 
student on how to fill in the food intake record/diary via completing a sample of 1-day 
food intake record will be practiced to ensure that you can accurately and sufficiently 
recorded your dietary intake. Also, instructions on how to fill in the Yale Physical 
Activity Survey (Yale) will be given to you. Then, you will be given the following forms: 
demographic questionnaire, food intake records (FIRs), and Yale Physical Activity 
Survey (Yale) to be completed at home. Also, in this visit, time and place for the second 
visit will be scheduled between the researcher student and the participating participant 
upon a mutual agreement to conduct the cognitive testing. 
 
You will be asked to fill in the following paper forms at home: 
• Demographic Questionnaire: You will be asked to provide basic information 
about your age, sex, education level, employment status, etc. This will take 
approximately 3 minutes to complete 
• 5-Day Food Intake Record: This form asks you to record all beverages, foods, 
and supplements consumed and all medication taken on 4 weekdays and 1 
weekend day, and it takes about 12 minutes to complete per day. 
• The Yale Physical Activity Questionnaire (Yale):  You will be asked to complete 
a short questionnaire to determine your current physical activity level, which will 
take about 10 minutes. 
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Visit2: (second and final study visit of 1-hour), you will return the following week for 
1- hour visit. In this visit, the participants will be given a copy of informed consent for 
their own records. Participants will also submit their completed demographic 
questionnaire, food intake record/diary and Yale and will also be checked by the 
researcher student for completion and clarity. Next cognitive testing will be administered 
by the researcher student, which will take approximately 30 minutes to complete both the 
actual tests and the practice session associated with each test. These tests will run in the 
following sequence-Victoria Stroop test, Trial Making test (part A and part B) and the 
digit span test (forward and backward) by using a personal computer. After each test, the 
participants will be asked whether they would like to take break or not and the 
opportunity to ask any questions. On completion of the protocol, you will be thanked for 
your time and if you would like to receive a research report summary of the study 
findings. 
 
In this visit, you will be asked to sit in front of a laptop computer screen to do the 
cognitive tasks in the following sequence: Victoria stroop test, Trial Making Test 
(part A +Part B) and the Digit span test (forward and backward) 
Below is a brief description about what you will encounter when you do each task: 
• Victoria Stroop test:  before the test begins, you will do a brief practice session to 
familiarize yourself with the test. In this test, you will press the key buttons {1,2, 
3 and 4} that corresponds to each of the following color {red, blue, yellow and 
green}. Next, the actual test will begin which will ask to press the correct key 
button that correspond to the color of the stimuli that you will see on the screen. 
For example, if the color of the stimuli is red, then, you have to press 1 that 
corresponds to the color of the stimuli. This test will take approximately 10 
minutes for  both the practice session and the actual test to complete. 
•  Trial Making Test (part A+ Part B):  before the test begins, you will do a brief 
practice session to familiarize yourself with the test. In this test, you will have to 
connect 26 blue circles “dots” arranged in a random order in the correct sequence. 
The test usually begins by clicking circle 1. For part A of this test, you have to 
connect numbers from 1-26 in the correct order. For example, 1-2-3-4 -----26. For 
part B, you will have to click on the circles in an alphanumeric order. For 
example,1-A-2-B-3-C and so on. If you click on the correct circle, a line will be 
drawn and the same process goes on until you connect the 26 dots. However, if 
you click on the wrong circle, no line will be drawn until you click on the correct 
one. This test will take approximately 7 minutes to complete both parts 
• Digit Span test  (forward and backward): before the actual test begins, the 
researcher student will perform a practice session on a piece of paper with you. In 
the forward version of this test, you will hear and visually see 3 numbers on the 
screen and you have to type in these numbers in the order you saw them. For 
example, if you see 123 on the screen, you have to type in 123 by using the 
keyboard. For backward version of this test, you will be asked however, to type in 
these numbers in the reverse order 321.  If you answer correct, you will move on 
to the next random numbers of 4 digits. This test will take approximately 8 
minutes to complete both versions.   
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Will being in this study help you in any way?  
We do not anticipate direct benefits to you from taking part in this research study. We 
hope that the information learned from this study can be used in the future to benefit 
other older adults residing in community. By doing this research, society will uncover the 
importance of consuming dairy products in relation to cognitive function. Also, it will 
help health professionals, especially dietitians to encourage and identify strategies to 
improve the consumption of dairy products in this population group in order to promote 
healthy brain functions.  
 
Participation: 
Participation in this study is completely voluntary. The participant may refuse to 
participate and withdraw from the study at anytime with no consequences in the future. 
Also, there will be few questions that are of personal nature and may not be comfortable 
for the participant to answer. You are free to refuse to answer these questions. If you 
should choose to withdraw from the study, the data collected from your visits will be 
discarded. You do not waive any legal rights by singing the consent form.  
 
Benefits and risks: 
Participants will not be paid for taking part in this research study. There will be no direct 
cost to the participant for being involved in this research study. As researchers, we do not 
anticipate any personal risk from participant participation in this study, but if you feel 
uncomfortable or upset at any time, please notify the interviewer. Your participation in 
the study is highly appreciated and it will help the research team gain and share 
knowledge in both academia and professional fields as well as benefit other older adults.  
 
Privacy and Confidentiality: 
Maintaining participant research records is our most important priority. However, we 
cannot guarantee an absolute confidentiality because your personal information may be 
disclosed if it is required by law. As research investigators, we have taken the following 
measures to keep your information and identity secure. Your name will be coded with a 
participant identification number throughout the study; your records will be locked in a 
cabinet in a secure office at the university for 5 years, no information that discloses your 
identity will be released without your specific consent to the disclosure when results 
reported in meetings, presentations, or publications. We will keep all study material for at 
least 5 years after the study results have been published and will be destroyed at the end 
of that time. Participants have the right to withdraw from the research study at any time. 
Also, if you chose to leave the research study, you may choose to have your collected 
information excluded from the study. However, if the participant completed the study and 
the results are published in a scientific journal, the research investigators cannot allow 
your data to be withdrawn at a later date. If the research study results have been 
published, none of your personal information will be identified at any point. This measure 
has been taken to ensure that no one has the ability to tell whether you have participated 
in this research study or not.  
 
Contact Information: 
If you have any questions about your rights, as a participant, you may contact: the office 
of Research Ethics at Western University, 519 661 3036.  
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If you have any further questions or concerns about this research, please feel free to 
contact us at the principle investigator: Dr. Alan Slamoni at 519 661 2111 ext. 83541 OR 
Mariam Ismail at 519 870 2102 
 
Thank you in advance for considering participation in this study! This letter is 
yours to keep for future reference.  
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I have read the letter of information; have had the ability to understand the nature of the 
research study. The research study has been explained to me and I agree to participate in 
this study. All questions have been answered to my satisfaction.  
 
I consent to participate in this research study as outlined in the letter of information  
Initial----------------------------- 
Name of participant (please print)------------------------------------ 
Signature------------------------------- 
Date------------------------------------------ 
 
Pearson obtaining the consent form (please print)--------------------------------- 
Initial---------------------- 
Signature------------------- 
Date----------------------- 
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Appendix D: Demographic Questionnaire 
 
Demographics Questionnaire       DO NOT put your name on this sheet  
 
Subject Code------------------------                                  Date-------------------------------- 
 
Demographics Questionnaire 
 
Please answer the following questions about yourself. This personal information will be 
held in strict confidence. Only averages from a large group will be reported at the end of 
data collection period. 
 
1. What is your age? ------------- Years old 
2. Weight------------lbs or Kg                       Height--------------cm or m    
             BMI (weight (kg)/Height (m^2) (calculated by the researcher) 
3. Gender: please circle  
o Males     
o Females 
4. What is your current marital status? Please circle 
o Single 
o Married  
o Common-law 
o Separated  
o Divorced  
o Widowed  
o Would prefer not to say--------- 
5. What is the highest level of education you have completed? Please specify Less 
than elementary school 
o Elementary 
o High school 
o Vocational/technical school 
o College 
o University:  Bachelor’s degree  
o University: Post-graduate degree 
o Professional degree (MD, JD, etc.) 
o Other, please specify------------------ 
6. What is your current employment status? Please circle  
o Employed Full-Time 
o Employed Part-Time 
o Retired 
o Would prefer not to say 
7. What is your current household income in Canadian dollars? 
o Under $25,000 
o $25,000-$49,000 
o $50,000-$74,000 
o $75,000-$99,000 
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o $100,000-$124,000 
o $125,000-$149,000 
o $150,000 or more 
o Would prefer not to say 
8. How many adults are supported by this household income (including yourself)? 
o 1 
o 2 
o 3 
o 4 
o 5 
o 6 or more 
9. Do you consume alcohol?  
o Never, former/current (please circle) 
o Yes, amount------------ 
10. Are you smoker- tobacco smoke 
o Current, if yes how many cigars per day-------------- 
o  Past smoker 
o Non-smoker  
11. Do you engage in physical activity 
o Yes 
o No 
12. Are you taking any supplements (e.g. vitamin D, multivitamin, iron, fish oil, 
etc.)? Yes, No (please circle). If so what kind------------- and why are you taking it 
(deficiency, just an extra, other)--------------- Please specify  
13. Have you ever been told by a doctor that you have (please circle all that apply)      
o Alzheimer disease, 
o Dementia 
o Memory problems 
o Hypertension (High blood pressure) 
o Dyslipidemia (High blood cholesterol) 
o Diabetes (High blood glucose) 
o Obesity (High waist circumference) 
o Depression 
o Anxiety 
o Stress 
o Physical disability such as vision or hearing problem 
o Other, please specify--------------------- 
14. Please list all of the medications that you are taking to treat the above-mentioned 
medical conditions (For example, for hypertension; Thiazide, for diabetes, 
Metformine, etc. or any other medical conditions ---------------------------------------
------------------------------------------------------------------------------- 
15. Are you consuming soft drinks?  
o Yes, how often------------ 
o No 
16. How would you rate your dietary pattern of consuming other food groups (fruits 
and vegetables, grain and meat)? 
o Good 
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o Bad 
o Moderate 
17. Do you engage in extracurricular activities (e.g. volunteering, book clubs, 
cognitive activities, others, please specify------------------------------------) 
o Yes 
o No 
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Appendix E: Pearson Product Moment Correlations (Dairy Products Intake) 
 RCFT-
Composite 
Score 
DSTB DST (F+B) MoCA Stroop 
Fat     -.360 (.043) 
Saturated fat -.361 (.042)     
Mono fat     -.408 (.031) 
Poly fat     -.494 
(.008)** 
Cholesterol -.358 (.044)     
Vitamin D .367 (.046) .390 (.033)    
Magnesium   .386 (.042) .362 (.049)  
Phosphorous    .470 (.012)  
Potassium  .370 (.041)  .376 (.042)  
Zinc    .402 (.034) -.431 (.022) 
Vitamin A  .390 (.027)  .400 (.023)  
Vitamin B2  .378 (.039)  .409 (.025)  
Note. Data are presented as Pearson-Product Moment correlation coefficient r (p-value) 
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
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Appendix F: Pearson Product Moment Correlations (Total Dietary Intake) 
 RCFT-Composite 
Score 
MoCA Stroop 
Poly fat   -.412 (.019) 
Vitamin D .358 (.044) .372 (.036)  
Calcium   -.457 (.009)** 
Magnesium  .507 (.003)**  
Phosphorus   -.370 (.037) 
Potassium  .430 (.014)  
Note. Data are presented as Pearson-Product Moment correlation coefficient r (p-value) 
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
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Appendix G: Rey Complex Figure Test and Recognition Trial (RCFT) 
 
 
Meyers, J., & Meyers, K. (1995). Rey Complex Figure Test and Recognition Trial 
Professional Manual: Psychological Assessment Resource, Inc.   
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Appendix H: Yale Physical Activity Survey (YPAS) 
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DiPietro, L., Caspersen, C.J., Ostfeld, A.M. ,& Nadel, E.R. (1993). A survey for 
assessing physical activity among older adults. Medicine and Science in Sports and 
Exercise, 25(5), 628-642 
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